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In addition to skeletal muscle dysfunction, cancer cachexia is a systemic disease involving remodeling of non-ンヰ 
muscle organs such as adipose and liver.  Impairment of mitochondrial function is associated with multiple ンヱ 
chronic diseases.  The tissue-specific control of mitochondrial function in cancer cachexia is not well-defined.  ンヲ 
This study determined mitochondrial respiratory capacity and coupling control of skeletal muscle, white ンン 
adipose tissue (WAT), and liver in colon-26 (C26) tumor-induced cachexia.  Tissues were collected from PBS-ンヴ 
injected weight-stable mice, C26 weight-stable mice, and C26 mice with moderate (10% weight loss) and ンヵ 
severe cachexia (20% weight loss).  The respiratory control ratio (RCR, an index of OXPHOS coupling ンヶ 
efficiency) was low in WAT during the induction of cachexia, due to high non-phosphorylating LEAK ンΑ 
respiration.  Liver RCR was low in C26 weight-stable and moderately cachexic mice due to reduced OXPHOS. ンΒ 
Liver RCR was further reduced with severe cachexia, where Ant2 but not Ucp2 expression was increased.  ンΓ 
Ant2 was inversely correlated with RCR in the liver (r=-0.547, p<0.01).  Liver cardiolipin increased in moderate ヴヰ 
and severe cachexia, suggesting this early event may also contribute to mitochondrial uncoupling.  Impaired ヴヱ 
skeletal muscle mitochondrial respiration occurred predominantly in severe cachexia, at complex I. These ヴヲ 
findings suggest that mitochondrial function is subject to tissue-specific control during cancer cachexia, ヴン 
whereby remodeling in WAT and liver arise early and may contribute to altered energy balance, followed by ヴヴ 
impaired skeletal muscle respiration.  We highlight an under-recognized role of liver and WAT mitochondrial ヴヵ 













Approximately half of all cancer patients undergo cachexia, a life-threatening comorbidity of cancer in ヵΑ 
which tumor-induced metabolic abnormalities contribute to hallmark clinical features such as involuntary weight ヵΒ 
loss and skeletal muscle atrophy (45, 58).  Despite impairing responsiveness to anti-cancer treatment and ヵΓ 
accounting for an estimated 20% of all cancer-related deaths (30), cachexia continues to be an under-ヶヰ 
recognized issue in cancer care, and a major source of frustration for patients and family members alike (50, ヶヱ 
58).  Because the root causes of cancer cachexia are not well-defined at present, effective treatment options ヶヲ 
remain elusive (22).  While research efforts often emphasize skeletal muscle pathophysiology, current ヶン 
frameworks describe a systemic condition in which multiple organs such as adipose, bone, brain, heart, and ヶヴ 
liver are remodeled to generate the cachectic phenotype (2, 45, 46).  Convincing evidence supports the ヶヵ 
existence of cross-talk mechanisms between several of these organs, and targeted manipulation of non-ヶヶ 
muscle organs rescue losses of body weight and muscle mass (34, 35).  The multi-organ involvement ヶΑ 
underscores the highly complex nature of cancer cachexia, whereby multiple mechanisms of metabolic ヶΒ 
disturbance may be responsible for the hallmark clinical manifestations. ヶΓ 
 Several lines of evidence implicate mitochondria in the pathogenesis of cancer cachexia (3, 13).  Αヰ 
Mitochondria are well known for their central role in cellular function due to their regulation of nutrient oxidation Αヱ 
and bioenergetics, diverse signaling pathways, and cell fate decisions (40).  Given these critical roles, Αヲ 
disturbances to mitochondria and their metabolic functions are implicated in aging, neurodegenerative disease, Αン 
and cancer (1, 5, 6, 49).  In particular, effects on mitochondrial respiration are important because oxidative Αヴ 
phosphorylation (OXPHOS), which couples the electron transfer system (ETS) to ADP phosphorylation, can Αヵ 
affect redox status, oxidative stress, mitochondrial dynamics, quality control, and hence the overall health of Αヶ 
the mitochondrial pool (40).  In cancer cachexia, mitochondrial function is most widely studied in skeletal ΑΑ 
muscle, with several mechanisms proposed to link mitochondrial functions to muscle mass.  Elevated oxidant ΑΒ 
emission could lead to protein degradation and muscle atrophy (39, 52).  Further, restricted ATP provision from ΑΓ 
impaired OXPHOS may cause energetic stress, downstream activation of protein degradation, and muscle Βヰ 
dysfunction (16, 52).  Indeed, recent reports found decreased complex I-linked OXPHOS capacity and coupling Βヱ 
efficiency in situ, and reduced coupling efficiency in vivo in skeletal muscle of rodents with cancer cachexia Βヲ 
(10, 23, 55).  These defects were observed at or near time-points at which marked cachexia already occurred, Βン 
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and are suggestive of muscle dysfunction secondary to global changes in systemic metabolism (27).  The Βヴ 
coupling and function of skeletal muscle respiration throughout the development of cancer cachexia, from early Βヵ 
to late stage, requires further investigation. Βヶ 
 In addition to skeletal muscle oxidative metabolism, considerable interest has been devoted to adipose ΒΑ 
tissue function as a cause of cachexia.  White adipose tissue depots undergo a phenotypic switch to resemble ΒΒ 
the more metabolically active, mitochondrial-dense, heat producing brown adipose compartment (i.e. WAT ΒΓ 
beiging/browning) (35, 44).  In other conditions characterized by severe metabolic stress and beiging (i.e. burn Γヰ 
injury), WAT shows high LEAK respiration (53), which reflects the permeability of the mitochondrial inner Γヱ 
membrane to inward electron flow and intrinsic uncoupling, thereby generating heat independent of ATP Γヲ 
synthase activity due to compensation for the dissipation of the proton gradient.  The metabolic rewiring of Γン 
WAT has been proposed as a source of elevated energy expenditure and thus involuntary weight loss (44, 53).  Γヴ 
It has also been suggested that inefficiency of OXPHOS and uncoupling in the liver could be another Γヵ 
mechanism by which energy is dissipated as heat, metabolic rate increases, and weight loss ensues (20, 46).  Γヶ 
It is not well-established, however, if mitochondrial defects in liver are part of cancer cachexia severity.   ΓΑ 
How mitochondrial respiration functions in skeletal muscle, WAT, and liver before overt features of ΓΒ 
cachexia occur, along with the extent to which they change as severe cachexia arises, is not known.  This ΓΓ 
investigation tested the hypotheses that mitochondrial respiration is subject to tissue-specific control ヱヰヰ 
mechanisms during the induction and progression of cancer cachexia, and that these indices of mitochondrial ヱヰヱ 
function relate to body weight loss and skeletal muscle atrophy, the hallmark features of cancer cachexia.  To ヱヰヲ 
address this, we assessed mitochondrial respiratory function by high-resolution respirometry during the ヱヰン 
induction and progression of cancer cachexia using the colon-26 (C26) tumor-bearing mouse model. ヱヰヴ 
 ヱヰヵ 
Methods ヱヰヶ 
Animals and design ヱヰΑ 
Ten-week old Balb/c males (Envigo) were randomly assigned to receive either an injection of PBS or ヱヰΒ 
colon-26 (C26) tumor cells.  The C26 tumor-bearing mouse is a well-established pre-clinical model of cancer ヱヰΓ 
cachexia (4, 18, 19, 33, 42, 61).  In this model the salient features of cachexia develop (i.e. weight loss, muscle ヱヱヰ 
atrophy) over a typical tumor growth period of 3 weeks.  Tissue was collected from C26 mice between day 14 ヱヱヱ 
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and 21 after tumor cell injection based on weight loss, followed by evaluation of mitochondrial function in ヱヱヲ 
groups stratified by cachexia severity according to the degree of weight loss, similar to previous investigations ヱヱン 
(7, 59).  The 4 groups studied included: 1) Tumor-free, weight-stable mice that were PBS injected (PBS-WS, ヱヱヴ 
n=4), 2) C26 mice with confirmed tumors that did not exhibit weight loss (weight-stable, C26-WS, n=6), 3) C26 ヱヱヵ 
mice with moderate cachexia (10% weight loss; C26-MOD, n=7), and 4) C26 mice with severe cachexia (≥20% ヱヱヶ 
weight loss; C26-SEV, n=6).  These classifications were adapted from prior pre-clinical investigations in which ヱヱΑ 
10% weight loss was considered moderate cachexia, and 20% severe (7, 59).  Weight loss for each mouse ヱヱΒ 
was calculated as the percentage change between carcass weight (i.e. tumor-free body weight) and body ヱヱΓ 
weight recorded on the day of cell injection.  For all C26-SEV mice, tissue was collected on day 21 post-ヱヲヰ 
injection.  For C26-MOD, tissue was collected on day 14 (n=4), 15 (n=1), 17 (n=1), or 21 (n=1).  For the C26-ヱヲヱ 
WS group, tissue was collected on day 14 (n=1), 20 (n=2), or 21 (n=3).  Mice were individually housed, ヱヲヲ 
provided food and water ad libitum, and maintained on a 12:12 hr light:dark cycle.  C26 tumor-bearing mice ヱヲン 
may or may not exhibit anorexia depending on the source of the C26 cells and the phenotype they induce (42).  ヱヲヴ 
The C26 cells in the present study were obtained from a cell bank that others have used to show no significant ヱヲヵ 
anorexia as a result of C26 tumor-induced cachexia (4).  All procedures were approved by the Institutional ヱヲヶ 
Animal Care and Use Committee at Florida Atlantic University (Protocol # A16-39). ヱヲΑ 
 ヱヲΒ 
C26 tumor cell culture and injection  ヱヲΓ 
C26 cells (CLS Cell Lines Service, Eppelheim, Germany) were cultured in a humidified 5% CO2 ヱンヰ 
incubator using complete media that contained RPMI 1640 supplemented with 1% penicillin/streptomycin ヱンヱ 
(vol/vol) and 10% FBS (vol/vol).  Media was replaced every two to three days.  At sub-confluency, cells were ヱンヲ 
harvested by incubation with trypsin (0.05%, Gibco) and subsequently pelleted by centrifugation.  The ヱンン 
supernatant was then discarded and the pellet resuspended in sterile PBS.  Viable cells were counted in a ヱンヴ 
hemocytometer by trypan blue staining and light microscopy.  Mice in C26 groups were gently restrained and ヱンヵ 
injected s.c. in the upper back with a cell suspension containing 1 x 106 cells.  Mice assigned to weight-stable ヱンヶ 





Tissue collection and processing ヱヴヰ 
Mice were euthanized by ketamine/xylazine overdose delivered i.p. (300/30 mg/kg).  Euthanasia was ヱヴヱ 
performed during a four-hour time window from 10:00 am to 2:00 pm to ensure consistency in the timing of ヱヴヲ 
tissue collection.  Mice were not food deprived overnight or immediately prior to tissue collection.  Hindlimb ヱヴン 
skeletal muscles, vital organs, and epididymal white adipose tissue (WAT) were carefully isolated and ヱヴヴ 
removed.  The left medial gastrocnemius, left epididymal WAT, and left lateral lobe of the liver, were ヱヴヵ 
immediately placed into ice-cold preservation buffer (BIOPS: 2.77 mM CaK2EGTA, 7.23 mM K2EGTA, 5.77 ヱヴヶ 
mM Na2ATP, 6.56 mM MgCl2び6H2O, 20 mM Taurine, 15 mM Na2PCr, 20 mM Imidazole, 0.5 mM DTT, 50 mM ヱヴΑ 
MES hydrate) and stored on ice in preparation for in situ analysis of mitochondrial respiration.  The ヱヴΒ 
gastrocnemius was selected because it is a major locomotor muscle that atrophies in this model (33), and has ヱヴΓ 
been previously used to investigate mitochondrial respiration in mouse studies of metabolic dysfunction (38, ヱヵヰ 
41).  Epididymal WAT was selected due to its anticipated remodeling and relative abundance, which ensured ヱヵヱ 
adequate tissue availability for the respirometric assay.  WAT was not detectable in severe cachexia, and was ヱヵヲ 
therefore not analyzed in the C26-SEV group.  The left lateral lobe of the liver was chosen in accordance with ヱヵン 
Heim et al (28).  The right hind limb muscles were mounted cross-sectionally in tragacanth gum on cork, and ヱヵヴ 
frozen in isopentane cooled by liquid nitrogen for histological analysis.  Remaining tissues were snap frozen ヱヵヵ 
and stored at -80°C.   ヱヵヶ 
To prepare WAT for respirometry, a portion of tissue was gently blotted dry, and two samples were ヱヵΑ 
prepared that weighed ~20-50 mg.  Samples were sectioned into 2-3 pieces prior to placement into the two ヱヵΒ 
respirometer chambers.  Chemical permeabilization of WAT by addition of digitonin into the chambers was not ヱヵΓ 
performed based on preliminary tests and reports by others in which no effect on respiratory capacity was ヱヶヰ 
observed (12).  Preparation of the liver for respirometry was adapted from previous work (36).  Briefly, a pair of ヱヶヱ 
small sections from the left lateral lobe (~6 mg each) were placed in a petri dish with ice-cold BIOPS and ヱヶヲ 
subjected to gentle mechanical separation with forceps under a dissecting microscope.  Duplicate liver ヱヶン 
samples were blotted dry on filter paper, weighed, and placed into the respirometer chambers.  To prepare ヱヶヴ 
skeletal muscle for respirometry, the gastrocnemius was placed in a petri dish containing ice-cold BIOPS and ヱヶヵ 
mechanically separated with sharp forceps into duplicate fiber bundles (~4-6 mg each) under a dissecting ヱヶヶ 
microscope (26, 43).  Fiber bundles were then permeabilized by placing them into separate wells of a 6-well ヱヶΑ 
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plate filled with BIOPS containing saponin (50 µgっml) and incubated with gentle shaking on ice for 20 minutes.  ヱヶΒ 
Following saponin treatment, fiber bundles were washed in respiration medium (MiR05) on ice with gentle ヱヶΓ 
shaking for 10 min (MiR05: 0.5 mM EGTA, 3 mM MgCl2, 60 mM K-lactobionate, 20 mM taurine, 10 mM ヱΑヰ 
KH2PO4, 20 mM HEPES, 110 mM Sucrose, and 1g/l BSA, pH 7.1).  After washing, the fiber bundles were ヱΑヱ 
gently blotted dry on filter paper and weighed before being placed into the respirometer chambers.   ヱΑヲ 
 ヱΑン 
High-resolution respirometry  ヱΑヴ 
In situ respiration was measured in the pre-determined order of WAT, liver, and skeletal muscle.  This ヱΑヵ 
sequence was based on reported stability of mitochondrial performance following storage in BIOPS, with ヱΑヶ 
skeletal muscle showing the greatest retention of respiratory function whereas WAT shows a more rapid ヱΑΑ 
decline (12).  Oxygen flux per tissue mass (pmol:s-1:mg-1) was recorded in real-time at 37°C in the oxygen ヱΑΒ 
concentration range of 550-350 nmol/ml using high-resolution respirometry (Oxygraph-2k, Oroboros ヱΑΓ 
Instruments, Innsbruck, AT) and Datlab software (Oroboros Instruments, Innsbruck, AT).  In WAT and liver, ヱΒヰ 
respiration was assessed by a substrate-uncoupler-inhibitor-titration (SUIT) protocol adapted from Porter et al. ヱΒヱ 
(47, 48) containing the following sequential injections: 1) 1 mM malate, 75 µM palmitoyl-carnitine, 5 mM ヱΒヲ 
pyruvate, and 10 mM glutamate, to determine non-phosphorylating LEAK respiration supported by complex I ヱΒン 
linked substrates (with fatty acids) (CIL); 2) 5 mM ADP to achieve maximal phosphorylating respiration from ヱΒヴ 
electron input through complex I (CIP); 3) 10 mM succinate to saturate complex II and achieve maximal ヱΒヵ 
convergent electron flux through complex I and II (CI+IIP); 4) 10 µM cytochrome c to assess the integrity of the ヱΒヶ 
outer mitochondrial membrane and hence quality of sample preparation (samples were rejected when flux ヱΒΑ 
increased by >15% (37)); 5) 0.5 µM carbonylcyanide m-cholorophenyl hydrazone (CCCP) to assess complex I ヱΒΒ 
and II linked ETS capacity (i.e. maximal capacity of the electron transfer system; CI+IIE); 6) 0.5 µM rotenone to ヱΒΓ 
inhibit complex I (CIIE); and 7) 2.5 µM Antimycin A to inhibit complex III and obtain residual oxygen ヱΓヰ 
consumption.  We note that in our evaluation of OXPHOS supported by complex I and II linked substrates (i.e. ヱΓヱ 
CIP, CI+IIP), a fatty acid was included in the protocol, therefore, electrons are also supplied into the respiratory ヱΓヲ 
chain via electron-transferring flavoprotein (43). ヱΓン 
For mitochondrial respiration in skeletal muscle, a similar SUIT protocol was followed with slight ヱΓヴ 
modifications to the sequence of injections in order to determine fatty acid based respiration (14): 1) 1 mM ヱΓヵ 
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malate and 75 µM palmitoyl-carnitine to determine LEAK respiration supported by fatty acids (FAOL); 2) 5 mM ヱΓヶ 
ADP to determine fatty acid OXPHOS capacity (FAOP); and 3) 5 mM pyruvate and 10mM glutamate to ヱΓΑ 
evaluate complex I supported OXPHOS capacity (with fatty acids) (CIP).  Subsequent assessment of CI+IIP, ヱΓΒ 
outer membrane integrity, CI+IIE, CIIE, and residual oxygen consumption were identical to steps 3-7 of the ヱΓΓ 
protocol used for WAT and liver. ヲヰヰ 
 ヲヰヱ 
Data reduction and analysis ヲヰヲ 
Oxygen fluxes of the different respiratory states were corrected by subtracting residual oxygen ヲヰン 
consumption following antimycin A treatment.  Fluxes from each duplicate measurement were averaged for ヲヰヴ 
statistical analysis.  To determine flux control ratios, which express respiratory control independent of ヲヰヵ 
mitochondrial volume-density, tissue mass-specific oxygen fluxes from the SUIT protocol were divided by ヲヰヶ 
maximal electron transfer system capacity (CI+IIE) as the reference state (43).  Because CI+IIE is an intrinsic ヲヰΑ 
indicator of mitochondrial function that represents the maximal capacity of the electron transfer system, it can ヲヰΒ 
be used to normalize the other respiratory states (43).  The respiratory control ratio (RCR), an index of ヲヰΓ 
coupling efficiency of the OXPHOS system, was calculated for WAT and liver in the complex I linked substrate ヲヱヰ 
state from the ratio of CIP to CIL (P/L) (11).  The inverse RCR in the complex I supported state (L/P) was also ヲヱヱ 
calculated.  To determine the fraction of maximal OXPHOS capacity serving LEAK respiration, the oxygen flux ヲヱヲ 
measured with complex I substrates but not adenylates, CIL, was divided by CI+IIP. (11, 43)  The substrate ヲヱン 
control ratio (SCR), which evaluates the change in oxygen flux by addition of substrate within a defined ヲヱヴ 
coupling state, was calculated for succinate (SCRsuccinate) as CI+IIP/CIP (48). ヲヱヵ 
 ヲヱヶ 
Total homogenate and subcellular fractionation ヲヱΑ 
Tissue homogenate (skeletal muscle, WAT, and liver) was prepared using a Potter-Elvehjem ヲヱΒ 
homogenizer containing 1 mL of ice-cold mitochondrial isolation buffer (215 mM mannitol, 75 mM sucrose, ヲヱΓ 
0.1% BSA, 20 mM HEPES, 1 mM EGTA, and pH adjusted to 7.2 with KOH), as previously described (56).  ヲヲヰ 
400 µl of tissue homogenate was frozen immediately in -80 °C for biochemical assays.  To isolate the ヲヲヱ 
mitochondria, the remaining tissue homogenate was centrifuged at 1,300 g for 3 min at 4 °C to obtain nuclear ヲヲヲ 
pellets.  The supernatant was further centrifuged at 10,000 g for 10 min at 4 °C to obtain mitochondrial pellets.  ヲヲン 
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The final mitochondrial pellet was resuspended in 40 µl isolation buffer.  The protein concentration of total ヲヲヴ 
homogenate and mitochondrial fraction was measured using the BCA protein assay kit. ヲヲヵ 
 ヲヲヶ 
H2O2 production ヲヲΑ 
Liver and skeletal muscle mitochondrial H2O2 production were measured using 50 たM Amplex Red ヲヲΒ 
(Cat#10187-606, BioVision) and 1 U/ml horseradish peroxidase (HRP) reagents at 30 °C as described ヲヲΓ 
previously (57).  The formation of fluorescent resorufin from Amplex red was measured after a 10 min period at ヲンヰ 
530-nm excitation and 590-nm emission filters using a Biotek Synergy HTX spectrofluorometer (Winooski, ヲンヱ 
VT).  ヲンヲ 
 ヲンン 
Citrate synthase activity ヲンヴ 
Citrate synthase (CS) was analyzed as a surrogate for mitochondrial volume-density in homogenized ヲンヵ 
liver and gastrocnemius tissues.  CS activity was not assayed in WAT due to limited tissue availability.  CS ヲンヶ 
activity was determined using a commercially available kit according to the manufacturer’s instructions ヲンΑ 
(MitoCheck® Citrate Synthase Activity Assay Kit, Cayman Chemical).  Absorbance was measured ヲンΒ 
spectrophotometrically in 30 second intervals for 20 minutes at 412 nm.  Samples were analyzed in duplicate ヲンΓ 
at a tissue concentration of 2 mg/ml.  CS activity was expressed as nM/min/µg protein. ヲヴヰ 
 ヲヴヱ 
Cardiolipin content ヲヴヲ 
The fluorescent dye 10-N-Nonyl-Acridine Orange (Cat # A7847, Sigma) was used to measure ヲヴン 
mitochondrial cardiolipin content (24, 25). Briefly, 50 µg of liver mitochondria and white adipocyte total protein ヲヴヴ 
homogenate was incubated with 50 µM of NAO reagent in mitochondrial isolation buffer at 30°C for 20 min in ヲヴヵ 
the dark.  After incubation, the red fluorescence of NAO bound to cardiolipin was measured at wavelengths of ヲヴヶ 
495 nm (excitation) and 519 nm (emission) with a Biotek spectrofluorometer. ヲヴΑ 
 ヲヴΒ 
Myofiber cross-sectional area ヲヴΓ 
Procedures for determining myofiber cross-sectional area (CSA) were performed as previously ヲヵヰ 
described (33).  Briefly, transverse sections 8 µm thick were sectioned from the mid-belly of the gastrocnemius ヲヵヱ 
ヱヰ 
 
on a cryostat at -20°C.  Sections were subsequently fixed with 10% formalin, stained with hematoxylin, washed ヲヵヲ 
with PBS, and coverslipped with Immu-Mount medium.  Images were acquired at 20x and analyzed by NIH-ヲヵン 
Image J software. ヲヵヴ 
 ヲヵヵ 
Western blotting ヲヵヶ 
A total of 30 たg of protein from total homogenate or mitochondrial fraction of liver and skeletal muscle ヲヵΑ 
were resolved by SDS-PAGE using 4–20% Criterion™ TGX™ Precast gels (Cat# 5671095, Bio-Rad, Hercules, ヲヵΒ 
CA).  The proteins were transferred onto polyvinylidene difluoride (PVDF) membranes, blocked with 6% nonfat ヲヵΓ 
dry milk or 5% BSA (for phospho-specific antibodies) for one hour at room temperature, and then incubated at ヲヶヰ 
4°C overnight with the primary antibody of interest.  The primary antibodies included: mitochondrial anti-ヲヶヱ 
adenine nucleotide translocase 2 rabbit mAb (Ant2, 1:2500 dilution, cat#14671), mitochondrial anti-uncoupling ヲヶヲ 
protein 2 rabbit mAb  (Ucp2, 1:2500 dilution, cat#89326), anti-phospho-AMP activated protein kinase g rabbit ヲヶン 
mAb (Thr172) (p-AMPKg, 1:2000, cat#2535), total anti-AMP activated protein kinase g rabbit polyAb (AMPKg, ヲヶヴ 
1:2000 dilution, cat#2532), anti-g-tubulin mouse mAb (1:5000, cat#3873) and mitochondrial anti-voltage ヲヶヵ 
dependent anion channel rabbit mAb (VDAC, 1:5000 dilution, cat#4661) from Cell Signaling Technology Inc.  ヲヶヶ 
The mitochondrial anti-creatine kinase 2 rabbit polyAb (CKMT2, 1:3000 dilution, cat#SAB2100437) was from ヲヶΑ 
Sigma-Aldrich.  For secondary antibodies, peroxidase-conjugated horse anti-mouse IgG (cat#7076) and goat ヲヶΒ 
anti-rabbit IgG (cat # 7074) were obtained from Cell Signaling Technology.  The immunoreactive protein ヲヶΓ 
reaction was revealed using SuperSignal™ West Pico PLUS Chemiluminescent Substrate (cat# PI34580, ヲΑヰ 
Thermo Fisher).  The reactive bands were detected by ChemiDocTM XRS+ imaging system (Bio-rad) and ヲΑヱ 
density measured using NIH ImageJ software.   ヲΑヲ 
 ヲΑン 
Statistical analysis ヲΑヴ 
All data are reported as mean±SE.  Group differences were determined by one-way ANOVA.  In the ヲΑヵ 
event of a significant F-test, post hoc analysis was conducted using Tukey’s HSD.  Pearson correlation ヲΑヶ 
coefficients (r) were used to determine the associations among mitochondrial respiration, percent body weight ヲΑΑ 
change, myofiber cross-sectional area and protein expression.  To obtain the proportion of shared variance ヲΑΒ 
ヱヱ 
 
between these variables, the coefficient of determination (R2) was calculated for each correlation by squaring ヲΑΓ 
the Pearson-r value.  Significance was accepted at p<0.05. ヲΒヰ 
 ヲΒヱ 
Results ヲΒヲ 
Weight loss and organ atrophy in colon-26 tumor-induced cachexia ヲΒン 
Body weight change averaged -10±1% in C26-MOD, and -22±2 % in C26-SEV, which were significantly ヲΒヴ 
different from PBS-WS and C26-WS (Fig. 1a).  Weight loss was also significantly greater in C26-SEV ヲΒヵ 
compared to C26-MOD (Fig. 1a).  Tumor burden increased in accordance with weight loss (Fig. 1b).  Muscle ヲΒヶ 
weights were ~20-30% lower in C26-MOD and C26-SEV compared to PBS-WS and C26-WS (Fig. 1c).  ヲΒΑ 
Epididymal fat was substantially depleted in C26-MOD relative to PBS-WS and C26-WS; epididymal fat was ヲΒΒ 
not detected in C26-SEV. (Fig. 1d).  The spleen was significantly enlarged in C26-WS and C26-MOD versus ヲΒΓ 
PBS-WS (+44-74%) (Fig. 1e), consistent with an inflammatory response to tumor load.  Although spleen mass ヲΓヰ 
was 34% greater in C26-SEV compared to PBS-WS, this did not reach statistical significance (p=0.183).   ヲΓヱ 
Absolute liver mass was lower in C26-MOD and C26-SEV compared to the WS groups (Fig. 1f).  Fiber cross-ヲΓヲ 
sectional area was ~45% lower in C26-MOD, and ~55% lower in C26-SEV compared to the WS groups (Fig. ヲΓン 
1g-h).  Fiber size distribution revealed the greatest percentage of small fibers in C26-SEV, followed by C26-ヲΓヴ 
MOD (Fig. 1i). ヲΓヵ 
 ヲΓヶ 
Impairment of complex I-supported skeletal muscle mitochondrial respiration in severe cachexia ヲΓΑ 
In comparison to PBS-WS and C26-WS, mass-specific fluxes for FAOL, FAOP, CIP, CI+IIP, and CI+IIE ヲΓΒ 
were lower in C26-MOD and C26-SEV (Fig. 2a), indicating a general cachexia-associated loss of muscle ヲΓΓ 
respiratory capacity per tissue mass under various substrate and coupling states.  In particular, CIP, CI+IIP, and ンヰヰ 
CI+IIE were 23-40% lower in C26-MOD, and 58-79% lower in C26-SEV (Fig. 2a).  Oxygen flux for select ンヰヱ 
substrate and coupling states were also lower in C26-SEV compared to C26-MOD (Fig. 2a), supportive of a ンヰヲ 
progressive deterioration in muscle mitochondrial function per tissue mass as cachexia severity increased.  ンヰン 
There were no differences in CS activity (p>0.05) (Fig. 2d), consistent with an impairment of skeletal muscle ンヰヴ 
respiration in cachexia as opposed to a reduced mitochondrial volume-density.  Mass-specific fluxes FAOL, ンヰヵ 
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FAOP, CIP, CI+IIP, and CI+IIE each related linearly with body weight change (r=0.689-0.804) and fiber CSA ンヰヶ 
(r=0.684-0.762) (Figs. S1a-e, h-l, doi.org/10.6084/m9.figshare.7880999.v2).   ンヰΑ 
Normalization of mass-specific fluxes to ETS capacity, an internal mitochondrial marker, yielded flux ンヰΒ 
control ratios that are independent of mitochondrial density, therefore providing an index of mitochondrial ンヰΓ 
quality.  The flux control ratio for FAOP (FAOP/CI+IIE) was 33% lower in C26-MOD (p=0.058), and 60% lower in ンヱヰ 
C26-SEV (p=0.001) compared to PBS-WS (data not shown).  FAOP/CI+IIE in C26-SEV was also lower than ンヱヱ 
C26-WS (-51%, p=0.007) and C26-MOD (-40%, p=0.086) (data not shown).  Suppression of fatty acid based ンヱヲ 
respiration may therefore depend on cachexia severity.  The flux control ratio for CIP (CIP/CI+IIE) was 44-53% ンヱン 
lower in C26-SEV compared to PBS-WS, C26-WS, and C26-MOD (Fig. 2b).  The lower ETS-normalized CIP in ンヱヴ 
C26-SEV suggests that muscle mitochondrial quality was impaired, primarily as a consequence of severe, late ンヱヵ 
stage cachexia, and that the source of this dysfunction may reside at complex I.  The substrate control ratio for ンヱヶ 
succinate, SCRsuccinate, was ~4-5-fold greater in C26-SEV compared to PBS-WS, C26-WS, and C26-MOD (Fig. ンヱΑ 
2c).  This may implicate a compensatory reliance of severely cachectic muscle on electron supply through ンヱΒ 
complex II in order to stimulate OXPHOS.  Body weight change related significantly with both CIP/CI+IIE ンヱΓ 
(r=0.487) and SCRsuccinate (r=-0.476) (Fig. S1f-g, doi.org/10.6084/m9.figshare.7880999.v2).   ンヲヰ 
H2O2 in the mitochondrial fraction of skeletal muscle was ~40-50% lower in C26-MOD and C26-SEV ンヲヱ 
compared to PBS-WS and C26-WS (Fig. 2e).  Phosphorylation of AMPK was ~100-150% greater in C26-WS ンヲヲ 
and C26-MOD compared to PBS-WS (Fig. 3a, c), indicating early activation of AMPK in skeletal muscle.  ンヲン 
CKMT2 expression in C26-MOD was ~4-fold greater than PBS-WS, and ~2-fold greater than C26-WS ンヲヴ 
(p=0.091) and C26-SEV (p=0.054) (Fig. 3b, d), consistent with energetically stressed skeletal muscle in early ンヲヵ 
cachexia.  Ant2 expression showed a similar pattern of response to CKMT2 (Fig. 3b, e).  ンヲヶ 
 ンヲΑ 
Increased respiratory rates and uncoupling in WAT during the induction of cancer cachexia ンヲΒ 
Mass-specific fluxes for WAT including CIL, CIP, CI+IIP, and CI+IIE were significantly greater in C26-ンヲΓ 
MOD compared to the WS groups (Fig. 4a), consistent with an increase in overall mitochondrial electron ンンヰ 
transport and respiratory capacity.  CIL in particular showed robust expansion, exceeding the WS groups by ンンヱ 
~200% (Fig. 4a).  This reflects greater leakiness of the inner mitochondrial membrane.  RCR for WAT was ンンヲ 
~50% lower in C26-MOD compared to the WS groups (Fig. 4b), suggesting loss of OXPHOS coupling ンンン 
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efficiency.  The LEAK to OXPHOS ratios L/P and CIL/CI+IIP were greater in C26-MOD by 85-94% and 55-86% ンンヴ 
respectively, compared to the WS groups (Figs. 4c-d).  Flux control ratio for CIL (CIL/CI+IIE) was also greater in ンンヵ 
C26-MOD, by 47-75%, compared to the WS groups (Fig. 4e).  These elevated LEAK ratios are consistent with ンンヶ 
uncoupled mitochondria.  Cardiolipin content was ~50% lower in C26-MOD compared with C26-WS (Fig. 4f).  ンンΑ 
CIL, CI+IIP, and CI+IIE were inversely related to body weight change (r=-0.772-0.834) and fiber CSA (r=-0.732-ンンΒ 
.817) (Figs. S2a-c, g-I, doi.org/10.6084/m9.figshare.7881110.v1), indicating elevated WAT metabolic capacity ンンΓ 
in weight-losing mice with smaller myofibers, and lower WAT metabolism in weight-stable mice with larger ンヴヰ 
myofibers.  Further, RCR for WAT was positively associated with body weight change and fiber CSA (r=0.709, ンヴヱ 
r=0.565) (Fig. S2d, j, doi.org/10.6084/m9.figshare.7881110.v1), whereas the LEAK ratios L/P and CIL/CI+IIP ンヴヲ 
related inversely with body weight change and fiber CSA (r=-0.628-0.789) (Fig. S2e-f, k-l, ンヴン 
doi.org/10.6084/m9.figshare.7881110.v1), suggesting uncoupled WAT mitochondria to be a feature of tumor-ンヴヴ 
induced weight loss and myofiber atrophy. ンヴヵ 
 ンヴヶ 
Severity dependent loss of liver OXPHOS coupling efficiency and elevated LEAK in C26 mice ンヴΑ 
Compared with PBS-WS, mass-specific respiration for CIL, CIP, CI+IIP, and CI+IIE were ~40-80% lower ンヴΒ 
in all three C26 groups, indicating loss of liver respiratory capacity due to cancer, and not cachexia per se, for ンヴΓ 
each coupling state (i.e. LEAK, OXPHOS, ETS) (Fig. 5a).  CS activity, a proxy for mitochondrial volume-ンヵヰ 
density, was not different between groups (p>0.05) (Fig. 5e), suggesting the impairment of liver respiratory ンヵヱ 
function to be independent of mitochondrial mass.  AMPK phosphorylation status, an upstream signal for PGC-ンヵヲ 
1g-dependent mitochondrial biogenesis, was not different between groups (p>0.05) (e.g. see Fig. 6b, e).  RCR ンヵン 
of the liver was ~25-60% lower in C26-WS, C26-MOD, and C26-SEV compared to PBS-WS (Fig. 5b).  C26-ンヵヴ 
SEV also had lower liver RCR than C26-MOD (Fig. 5b).  Together this may signify a severity dependent loss of ンヵヵ 
OXPHOS coupling efficiency due to cancer, which subsequently worsens when severe cachexia develops. ンヵヶ 
CIL/CI+IIP was greater in C26-WS (+82%), C26-MOD (+74%), and C26-SEV (+93%) compared to PBS-ンヵΑ 
WS (Fig. 5c), consistent with an early, sustained increase in the fraction of maximal OXPHOS capacity that is ンヵΒ 
LEAK due to cancer rather than cachexia.  The P/E ratio (CI+IIP/CI+IIE) was greater in C26-SEV compared to ンヵΓ 
all other groups (Fig. 5d).  Because P/E in C26-SEV approached 1.0 (0.94±0.05), this may indicate dyscoupled ンヶヰ 
liver mitochondria in severe cancer cachexia.   ンヶヱ 
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Mass-specific respiration was positively related to body weight change (r=0.382-0.430) and fiber CSA ンヶヲ 
(r=0.395-0.459) (Figs. S3a-c, g-j, doi.org/10.6084/m9.figshare.7881143.v1), suggesting that depression in liver ンヶン 
mitochondrial function may be linked to cachexia-related weight loss and fiber atrophy.  Liver RCR (r=0.497) ンヶヴ 
was positively associated with weight change.  Thus, LEAK ratios L/P (r=-0.569) and CIL/CI+IIE (r=-0.484) were ンヶヵ 
inversely related to weight change (Figs. S3d-f, doi.org/10.6084/m9.figshare.7881143.v1). This suggests that ンヶヶ 
liver mitochondria with tighter coupling appeared more often in weight-stable mice, whereas uncoupling ンヶΑ 
typically appeared with weight loss. ンヶΒ 
 ンヶΓ 
Decreased ROS, increased cardiolipin, and greater Ant2 expression in cachectic liver mitochondria ンΑヰ 
To identify events associated with uncoupling of OXPHOS and elevated LEAK, we measured H2O2 ンΑヱ 
production and cardiolipin content by amplex red and NAO fluorescence, respectively, in the mitochondrial ンΑヲ 
fraction of the liver.  H2O2 is an indicator of mitochondrial ROS emission, and uncoupling may occur as a ンΑン 
protective response against high levels of ROS.  H2O2 declined in a severity-dependent manner compared to ンΑヴ 
PBS-WS (Fig. 5f).  This gradual decline in ROS emission paralleled the decrease in respiratory capacity, and ンΑヵ 
may represent part of a broad, cachexia-associated loss of liver mitochondrial function.  Cardiolipin, a ンΑヶ 
phospholipid of the mitochondrial inner membrane that regulates OXPHOS function, was ~40% greater in C26-ンΑΑ 
MOD and C26-SEV compared to C26-WS (Fig. 5g).  The greater cardiolipin content in both groups of ンΑΒ 
cachectic mice may support an involvement of this mitochondrial phospholipid in the uncoupling of liver ンΑΓ 
OXPHOS in cancer cachexia.  We next probed for Ucp2 and Ant2 expression in liver mitochondria by ンΒヰ 
immunoblotting to determine whether proteins with reported uncoupling properties may be associated with the ンΒヱ 
increased LEAK respiration and uncoupling of OXPHOS (Fig. 6a).  Ucp2 protein expression was not ンΒヲ 
significantly different between groups (p>0.05) (Fig. 6a, c).  However, Ant2 protein expression was significantly ンΒン 
greater in C26-SEV compared to PBS-WS, C26-WS, and C26-MOD, by 30%, 15%, and 16%, respectively ンΒヴ 
(Fig. 6a, d).  There was a significant inverse relationship between Ant2 expression and RCR in the liver (r=-ンΒヵ 







We report tissue-specific alterations in mitochondrial function during colon-26 tumor-induced cachexia.  ンΓヱ 
The progression and characteristics of mitochondrial function adaptations differed among skeletal muscle, liver ンΓヲ 
and WAT; but there were no differences in CS activity, consistent with impaired respiratory control that was ンΓン 
independent of changes in tissue mitochondrial volume-density.  In liver, ETS and OXPHOS capacity and RCR ンΓヴ 
decreased in tumor-bearing mice, even before weight loss was observed.  Weight loss and muscle atrophy ンΓヵ 
was linearly correlated with these effects. The impairment of liver mitochondrial respiration was associated with ンΓヶ 
increased cardiolipin and Ant2 but not Ucp2 expression. These data suggest roles for Ant2 and cardiolipin in ンΓΑ 
uncoupling of liver OXPHOS.  In WAT, the first effects on mitochondrial respiration were observed in mice with ンΓΒ 
moderate cachexia. The induction of moderate cachexia was associated with an increase in ETS and ンΓΓ 
OXPHOS capacities, an increase in non-phosphorylating LEAK respiration, and a decrease in RCR, consistent ヴヰヰ 
with the uncoupling of respiration from ATP synthesis.  Weight loss and muscle atrophy were linearly ヴヰヱ 
correlated with these effects.  In skeletal muscle, ETS and OXPHOS capacity were reduced in severe ヴヰヲ 
cachexia.  Adaptation in mitochondrial respiratory control in skeletal muscle resided at complex I.  Overall, ヴヰン 
mitochondrial respiratory variables in liver, WAT, and skeletal muscle accounted for a significant proportion of ヴヰヴ 
the variance in body weight change and myofiber size (Figs. S1, S2, S3).  These findings suggest that ヴヰヵ 
mitochondrial function is subject to tissue-specific control during cancer cachexia, whereby early alterations ヴヰヶ 
arise in liver and WAT, followed by later impairment of skeletal muscle respiration (Fig. 7). ヴヰΑ 
Skeletal muscle is the most widely studied organ in cancer cachexia.  Several pre-clinical investigations ヴヰΒ 
examined in situ mitochondrial respiration in skeletal muscle using a cross-sectional design comparing controls ヴヰΓ 
and tumor-bearing rodents with marked cachexia.   Impaired complex I and complex II OXPHOS were reported ヴヱヰ 
(23, 31), consistent with a loss of mitochondrial respiratory capacity and altered respiratory control in severely ヴヱヱ 
cachectic skeletal muscle.  We expand upon these findings by evaluating in situ respiration across a range of ヴヱヲ 
coupling states and substrate conditions, in tissue obtained from tumor-bearing mice with varying degrees of ヴヱン 
cachexia severity.  In skeletal muscle, reduction in mass-specific complex I and complex I+II OXPHOS and ヴヱヴ 
ETS capacities only occurred in severe cachexia, suggesting that altered skeletal muscle mitochondrial ヴヱヵ 
respiration is not an early event in cancer cachexia.  Loss of muscle mass and fiber CSA were evident in mice ヴヱヶ 
with moderate cachexia despite no significant impairment of complex I and II linked respiration compared with ヴヱΑ 
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saline control.  The exception to this was that fatty acid driven respiratory capacity (i.e. FAOL, FAOP) was ヴヱΒ 
reduced in moderate cachexia and remained suppressed in the severe state.   ヴヱΓ 
Since these parameters represent tissue mass-specific fluxes and do not account for changes in ヴヲヰ 
mitochondrial volume-density, we also calculated flux control ratios by normalization to maximal ETS capacity ヴヲヱ 
to provide indices of mitochondrial quality that are independent of mitochondrial density.  The flux control ratio ヴヲヲ 
for complex I OXPHOS in skeletal muscle was impaired only in severe cachexia, consistent with the notion that ヴヲン 
muscle mitochondrial dysfunction occurred only in late-stage cachexia.  The substrate control ratio for ヴヲヴ 
succinate was ~4-5 fold greater in severe cachexia, an apparent compensation for complex I dysfunction, to ヴヲヵ 
stimulate OXPHOS via complex II.  Impairment in OXPHOS capacity could contribute to energetic stress in ヴヲヶ 
skeletal muscle of cachectic mice.  We found that phosphorylation of AMPK was increased early, in weight-ヴヲΑ 
stable C26 mice, and remained elevated in moderate cachexia.  This implies that energetic stress precedes ヴヲΒ 
protein degradation and muscle atrophy.  The ~2-4-fold increase in mitochondrial creatine kinase (CKMT2) ヴヲΓ 
expression in moderate cachexia is consistent with this implication; this could represent a compensatory ヴンヰ 
adaptation to protect oxidative energy provision in skeletal muscle (56).  A similar expression pattern was seen ヴンヱ 
for Ant2, an ADP transport protein, suggesting that Ant2 may also be involved in this compensation.  In ヴンヲ 
addition to impaired OXPHOS, dysfunctional mitochondria may generate high levels of ROS that in turn affects ヴンン 
protein turnover and causes atrophy.  We did not observe increased H2O2 in the mitochondrial fraction of ヴンヴ 
skeletal muscle as anticipated.  H2O2 production actually declined in moderate and severe cachexia (perhaps ヴンヵ 
consequent to reduced ETS capacity in these conditions) and does not appear associated with muscle atrophy ヴンヶ 
in this model.  ヴンΑ 
The elevated rates of mitochondrial respiration in WAT were not surprising.  A recent report found ヴンΒ 
increased oligomycin and FCCP induced respiration in white adipocytes treated with parathyroid hormone-ヴンΓ 
related protein, a tumor-derived product that induces beiging (35).  Others found increased respiratory capacity ヴヴヰ 
of beige-like WAT in cachectic mice using glycerol-3-phosphate as a substrate (44).  Our data extends these ヴヴヱ 
findings by evaluating in situ respiration of WAT in a broader spectrum of coupling and substrates states.  A ヴヴヲ 
unique finding was the increase in coupled (phosphorylating) respiration with electron input through complex I ヴヴン 
and complex I+II, which to our knowledge has not been previously reported.  Upregulation of TCA cycle, ヴヴヴ 
electron transport, and OXPHOS genes in WAT of cancer patients with cachexia has been documented by ヴヴヵ 
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others (17), and our elevated OXPHOS and ETS capacities are consistent with that gene profile.  The increase ヴヴヶ 
in phosphorylating respiration could be a compensatory response to mitochondrial uncoupling in WAT, leading ヴヴΑ 
to increased energy expenditure.  Alternatively, increased OXPHOS and ETS capacity could be related to ヴヴΒ 
lipolysis and intracellular accumulation of free fatty acids.  Treatments that inhibit coupling and ATP synthesis ヴヴΓ 
are believed to suppress lipogenesis in adipose tissue (9, 51).  Further, insulin-dependent suppression of ヴヵヰ 
lipolysis may depend on ATP availability (9, 54).  Thus, increased phosphorylating respiration capacity may be ヴヵヱ 
a compensatory effort to provide the energy supply to promote lipogenesis and/or suppress lipolysis, in order ヴヵヲ 
to maintain adipose mass in the face of tumor-induced catabolism. ヴヵン 
While coupled respiration of WAT increased in early cachexia, the LEAK state increased dramatically.  ヴヵヴ 
By dividing coupled and LEAK respiration (in the same complex I-linked substrate conditions), we obtained the ヴヵヵ 
respiratory control ratio (RCR), an index of OXPHOS coupling efficiency.  Because LEAK expanded to a much ヴヵヶ 
larger degree relative to coupled respiration, WAT RCR decreased in early cachexia relative to weight-stable ヴヵΑ 
mice.  The presence of elevated LEAK was a consistent finding in this study, with greater WAT LEAK in early ヴヵΒ 
cachexia even when normalized to maximal OXPHOS and ETS capacities.  These findings are significant ヴヵΓ 
because they imply increased resting energy expenditure.  In burn injury, WAT undergoes browning and shows ヴヶヰ 
high LEAK respiration in parallel with elevated resting energy expenditure.  Reprogramming of WAT ヴヶヱ 
metabolism in this manner could potentially contribute to hypermetabolism in cancer cachexia.  Therapies that ヴヶヲ 
normalize WAT mitochondrial function by reducing LEAK and promoting tighter OXPHOS coupling may be ヴヶン 
beneficial.  ヴヶヴ 
Despite exerting major control over systemic metabolism, mitochondrial function in liver is not well ヴヶヵ 
studied in cancer cachexia.  Therefore, we measured in situ respiration in permeabilized liver samples.  The ヴヶヶ 
three C26 groups all showed significantly lower oxygen flux compared to PBS-injected mice, suggesting that ヴヶΑ 
the tumor was mainly responsible for impairment of hepatic mitochondrial respiration per unit of tissue mass.  ヴヶΒ 
RCR was also lower in all three C26 groups, although C26 mice with severe cachexia had the greatest decline.  ヴヶΓ 
These data suggest that early loss of OXPHOS coupling efficiency in the liver arises from tumor load, and ヴΑヰ 
subsequently worsens as cachexia severity increases.  Consistent with this, the P/E ratio was greatest in mice ヴΑヱ 
with severe cachexia.  A P/E ratio that approaches 1, as was the case in the severely cachectic mice, implies ヴΑヲ 
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the presence of dyscoupled mitochondria (i.e. pathologically uncoupled) (43) that would be energetically ヴΑン 
inefficient, and increase resting energy expenditure. ヴΑヴ 
We are aware of only a few prior investigations on liver mitochondrial energetics in cancer cachexia.  ヴΑヵ 
Using rats bearing the peritoneal carcinoma as a model of cancer cachexia, Dumas et al. reported reduced ヴΑヶ 
P/O and increased energy wasting in liver mitochondria (20), events consistent with our finding of reduced liver ヴΑΑ 
RCR.  They also found the increased energy wasting to be associated with greater cardiolipin content ヴΑΒ 
(R2=0.64).  In the present work, cardiolipin content increased in moderate cachexia, and stayed elevated in the ヴΑΓ 
severe state, consistent with their findings.  The expansion of cardiolipin mass in liver is of note given that in ヴΒヰ 
the elderly, and in many pathologies (e.g. heart failure, Barth syndrome, ischemia-reperfusion injury),  ヴΒヱ 
modifications to cardiolipin profiles typically consist of decreased content, altered fatty acid composition, and/or ヴΒヲ 
peroxidation (15).  We are unable to address whether changes in composition occurred, however the ヴΒン 
decreased H2O2 in liver mitochondrial lysates during cachexia suggests minimal peroxidation due to ヴΒヴ 
mitochondrial ROS emission.  We cannot exclude the possibility, though, of low antioxidant capacity and high ヴΒヵ 
oxidative stress.  Treatment of normal liver mitochondria with cardiolipin-enriched liposomes has been shown ヴΒヶ 
to adversely affect ATP synthesis and increase non-phosphorylating respiration, offering a possible ヴΒΑ 
explanation for the significance of enhanced liver cardiolipin in cancer cachexia (21, 32). ヴΒΒ 
The role of Ant in mediating cachexia-associated energy wasting has received some attention (32).  Ant ヴΒΓ 
is an ADP/ATP exchanger in the inner mitochondrial membrane that has uncoupling capability.  Treatment of ヴΓヰ 
liver mitochondria from cachectic rats with carboxyatractylate, an inhibitor of Ant, did not mitigate energy ヴΓヱ 
wasting, suggesting that Ant is not a major contributor to LEAK respiration in liver mitochondria from cachectic ヴΓヲ 
rodents.  Therefore, inefficiency of OXPHOS and energy wasting may depend on cardiolipin, but not Ant.  ヴΓン 
However, we observed a significant inverse relationship between Ant2 and RCR in the liver, suggesting a ヴΓヴ 
potential role for Ant2 expression to be involved in uncoupling.  Direct manipulations of liver Ant2 are ヴΓヵ 
necessary to better understand the role of this molecule in OXPHOS function in cancer cachexia.  We also ヴΓヶ 
anticipated an increase in Ucp2 expression in liver mitochondria from C26 mice with cachexia.  Although Ucp2 ヴΓΑ 
expression was ~2-fold greater in C26 mice compared to PBS-WS, this did not reach statistical significance.  ヴΓΒ 
Therefore, the increased LEAK respiration and uncoupling of OXPHOS does not appear to be mediated by ヴΓΓ 
Ucp2, at least in colon-26 tumor-induced cachexia.  These findings bring attention to the previously ヵヰヰ 
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underappreciated role of liver mitochondrial function in cancer cachexia, and suggest a benefit of therapies that ヵヰヱ 
improve mitochondrial function of the liver. ヵヰヲ 
We note several limitations in this investigation.  Food intake measurements were incomplete and are ヵヰン 
therefore not reported.  This information is needed to determine whether or not tumor-induced anorexia is ヵヰヴ 
present, and by extension if muscle mass changes relate in part to energy intake.  A previous study using C26 ヵヰヵ 
cells sourced from the same bank reported no anorexia in cachexic C26 mice (4), and this could be a possible ヵヰヶ 
indication that our C26 mice would also not exhibit significant anorexia.  However, this suggestion remains to ヵヰΑ 
be verified.  Food intake and nutrient absorption are also important, due to the potential impact of fed versus ヵヰΒ 
prolonged fasted states on OXPHOS and ETS capacity (29).  Furthermore, assessment of whole body ヵヰΓ 
metabolism was not performed, and this would have been a key addition in order to relate alterations at the ヵヱヰ 
mitochondrial level to the whole body.  For instance, the broader physiological significance of tissue-specific ヵヱヱ 
changes in mitochondrial respiration could be demonstrated by their relationship to a whole body measurement ヵヱヲ 
such as resting energy expenditure, which is elevated in cachexia.  Another important consideration is the ヵヱン 
identification of upstream triggers, such as tumor-derived products, that may be responsible for the effects we ヵヱヴ 
observed.  Others have reported interleukin-6 and parathyroid hormone-related protein to be triggers of white ヵヱヵ 
adipose beiging (35, 44), and they could be possible candidates for our mitochondrial alterations in adipose.  ヵヱヶ 
Whether inflammatory cytokines or tumor-derived products account for our observed effects in liver are ヵヱΑ 
uncertain.  We did not analyze tumors or plasma to screen for potential triggers of mitochondrial dysregulation, ヵヱΒ 
and this merits further experimental consideration.   ヵヱΓ 
Lastly, we note that our tissue collection methods were adopted from prior investigations with ヵヲヰ 
modifications in order to attain 10% and 20% weight loss in moderate and severe cachexia, respectively.  Body ヵヲヱ 
weight was routinely monitored to determine the timing of tissue collection, however, any measurement taken ヵヲヲ 
before sacrifice would be confounded by tumor weight.  Thus, we drew upon our previous experience with this ヵヲン 
model, anticipating a final tumor mass at necropsy of ~2g with severe cachexia (20% weight loss), and tumor ヵヲヴ 
mass of ~1g at moderate (10% weight loss).  For the typical adult Balb/c male weighing 25g, 1g tumor mass ヵヲヵ 
would account for ~3-4% of body weight.  During routine monitoring, a mouse showing ~7% weight loss would ヵヲヶ 
be euthanized in anticipation of tumor mass accounting for ~3-4% of body weight, in order to attain the target ヵヲΑ 
weight loss of 10% for the moderate cachexia group.  This deviates somewhat in comparison to other groups ヵヲΒ 
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that also study cachexia severity in the C26 model.  For instance, Zimmers laboratory use 5%, 10%, and 15% ヵヲΓ 
weight loss for mild, moderate, and severe cachexia, respectively (8).  When one group of mice reaches 10% ヵンヰ 
weight loss (weight measurements include the tumor), all other groups are euthanized (8).  This uniform timing ヵンヱ 
of tissue collection differed from the present work, and this methodological difference should be considered ヵンヲ 
when making comparisons between investigations. ヵンン 
In conclusion, we provide evidence for tissue-specific adaptation in mitochondrial respiratory control in ヵンヴ 
colon-26 tumor-induced cachexia.  Impairment of skeletal muscle mitochondrial OXPHOS occurred ヵンヵ 
predominantly in severe, late stage cachexia, whereas negative adaptations in mitochondria of liver and WAT, ヵンヶ 
including increased LEAK and reduced coupling control, were found earlier in cachexia progression and could ヵンΑ 
contribute to increased whole body energy expenditure and involuntary weight loss characteristic of cancer ヵンΒ 
cachexia.  Together these findings suggest mitochondrial function of multiple tissues to be potential sites of ヵンΓ 
targeted therapies. ヵヴヰ 
 ヵヴヱ 
Perspectives and Significance ヵヴヲ 
 There are currently no approved treatments for cancer cachexia, which occurs in up to 80% of ヵヴン 
advanced cancer patients and accounts for an estimated 20% of cancer-related deaths.  Paths toward effective ヵヴヴ 
treatments are complicated in part by the systemic nature of the disease, where dysfunction of multiple organs ヵヴヵ 
contributes to the cachexic phenotype.  Unraveling the mechanisms by which multi-organ remodeling ヵヴヶ 
contributes to cachexia are necessary in order to devise supportive care and treatment strategies that improve ヵヴΑ 
the lives of affected cancer patients.  Here we contribute to the understanding of some of these mechanisms.  ヵヴΒ 
We identify tissue-specific responses that mitochondria undergo at varying degrees of cachexia severity.  We ヵヴΓ 
show that mitochondria in both muscle and non-muscle organs (liver, adipose) are involved in the onset of ヵヵヰ 
moderate cachexia, and appear to also regulate progression towards a severe presentation of the disease.  ヵヵヱ 
Targeting mitochondrial function in a variety of tissue types, and defining how those targeted manipulations ヵヵヲ 
impact cachexia onset and progression, are important next steps to show which mitochondrial mechanisms ヵヵン 
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ヱく AﾐSヴW┌┝ PAが Hﾗ┌デﾆﾗﾗヮWヴ RHが ;ﾐS A┌┘Wヴ┝ Jく Pｴ;ヴﾏ;IﾗﾉﾗｪｷI;ﾉ ;ヮヮヴﾗ;IｴWゲ デﾗ ヴWゲデﾗヴW ﾏｷデﾗIｴﾗﾐSヴｷ;ﾉ a┌ﾐIデｷﾗﾐく N;デ ヵΒヶ 
RW┗ Dヴ┌ｪ DｷゲIﾗ┗ ヱヲぎ ヴヶヵどヴΒンが ヲヰヱンく ヵΒΑ 
ヲく AヴｪｷﾉWゲ JMが B┌ゲケ┌Wデゲ Sが SデWﾏﾏﾉWヴ Bが ;ﾐS LﾗヮW┣どSﾗヴｷ;ﾐﾗ FJく C;ﾐIWヴ I;IｴW┝ｷ;ぎ ┌ﾐSWヴゲデ;ﾐSｷﾐｪ デｴW ﾏﾗﾉWI┌ﾉ;ヴ H;ゲｷゲく ヵΒΒ 
N;デ RW┗ C;ﾐIWヴ ヱヴぎ ΑヵヴどΑヶヲが ヲヰヱヴく ヵΒΓ 
ンく AヴｪｷﾉWゲ JMが LﾗヮW┣どSﾗヴｷ;ﾐﾗ FJが ;ﾐS B┌ゲケ┌Wデゲ Sく M┌ゲIﾉW ┘;ゲデｷﾐｪ ｷﾐ I;ﾐIWヴぎ デｴW ヴﾗﾉW ﾗa ﾏｷデﾗIｴﾗﾐSヴｷ;く C┌ヴヴ Oヮｷﾐ Cﾉｷﾐ ヵΓヰ 
N┌デヴ MWデ;H C;ヴW ヱΒぎ ヲヲヱどヲヲヵが ヲヰヱヵく ヵΓヱ 
ヴく Aゲゲｷ Mが DWヴHヴW Fが LWaW┌┗ヴWどOヴaｷﾉ; Lが ;ﾐS RWHｷﾉﾉ;ヴS Aく Aﾐデｷﾗ┝ｷS;ﾐデ ゲ┌ヮヮﾉWﾏWﾐデ;デｷﾗﾐ ;IIWﾉWヴ;デWゲ I;IｴW┝ｷ; ヵΓヲ 
SW┗WﾉﾗヮﾏWﾐデ H┞ ヮヴﾗﾏﾗデｷﾐｪ デ┌ﾏﾗヴ ｪヴﾗ┘デｴ ｷﾐ Cヲヶ デ┌ﾏﾗヴどHW;ヴｷﾐｪ ﾏｷIWく FヴWW R;SｷI Bｷﾗﾉ MWS Γヱぎ ヲヰヴどヲヱヴが ヲヰヱヶく ヵΓン 
ヵく B;ﾆWヴ MJが P;ﾉﾏWヴ CSが ;ﾐS Sデﾗﾃ;ﾐﾗ┗ゲﾆｷ Dく MｷデﾗIｴﾗﾐSヴｷ;ﾉ ヮヴﾗデWｷﾐ ケ┌;ﾉｷデ┞ Iﾗﾐデヴﾗﾉ ｷﾐ ｴW;ﾉデｴ ;ﾐS SｷゲW;ゲWく Bヴ J ヵΓヴ 
Pｴ;ヴﾏ;Iﾗﾉ ヱΑヱぎ ヱΒΑヰどヱΒΒΓが ヲヰヱヴく ヵΓヵ 
ヶく B;ﾆWヴ MJが T;デゲ┌デ; Tが ;ﾐS L;ﾐｪWヴ Tく Q┌;ﾉｷデ┞ Iﾗﾐデヴﾗﾉ ﾗa ﾏｷデﾗIｴﾗﾐSヴｷ;ﾉ ヮヴﾗデWﾗゲデ;ゲｷゲく CﾗﾉS Sヮヴｷﾐｪ H;ヴH PWヴゲヮWIデ Bｷﾗﾉ ヵΓヶ 
ンぎ ヲヰヱヱく ヵΓΑ 
Αく BﾗﾐWデデﾗ Aが A┞SﾗｪS┌ Tが K┌ﾐ┣W┗ｷデ┣ﾆ┞ Nが G┌デデヴｷSｪW DCが Kｴ┌ヴｷ Sが Kﾗﾐｷ;ヴｷゲ LGが ;ﾐS ZｷﾏﾏWヴゲ TAく STATン ;Iデｷ┗;デｷﾗﾐ ｷﾐ ヵΓΒ 
ゲﾆWﾉWデ;ﾉ ﾏ┌ゲIﾉW ﾉｷﾐﾆゲ ﾏ┌ゲIﾉW ┘;ゲデｷﾐｪ ;ﾐS デｴW ;I┌デW ヮｴ;ゲW ヴWゲヮﾗﾐゲW ｷﾐ I;ﾐIWヴ I;IｴW┝ｷ;く PﾉﾗS ﾗﾐW ヶぎ WヲヲヵンΒが ヲヰヱヱく ヵΓΓ 
Βく BﾗﾐWデデﾗ Aが R┌ヮWヴデ JEが B;ヴヴWデﾗ Rが ;ﾐS ZｷﾏﾏWヴゲ TAく TｴW Cﾗﾉﾗﾐどヲヶ C;ヴIｷﾐﾗﾏ; T┌ﾏﾗヴどHW;ヴｷﾐｪ Mﾗ┌ゲW ;ゲ ; MﾗSWﾉ ヶヰヰ 
aﾗヴ デｴW Sデ┌S┞ ﾗa C;ﾐIWヴ C;IｴW┝ｷ;く J Vｷゲ E┝ヮ ヲヰヱヶく ヶヰヱ 
Γく Bﾗ┌Sｷﾐ; Sが ;ﾐS Gヴ;ｴ;ﾏ TEく MｷデﾗIｴﾗﾐSヴｷ;ﾉ a┌ﾐIデｷﾗﾐっS┞ゲa┌ﾐIデｷﾗﾐ ｷﾐ ┘ｴｷデW ;SｷヮﾗゲW デｷゲゲ┌Wく E┝ヮ Pｴ┞ゲｷﾗﾉ ΓΓぎ ヱヱヶΒどヶヰヲ 
ヱヱΑΒが ヲヰヱヴく ヶヰン 
ヱヰく Bヴﾗ┘ﾐ JLが Rﾗゲ;どC;ﾉS┘Wﾉﾉ MEが LWW DEが Bﾉ;Iﾆ┘Wﾉﾉ TAが Bヴﾗ┘ﾐ LAが PWヴヴ┞ RAが H;┞ﾐｷW WSが H;ヴSWW JPが C;ヴゲﾗﾐ JAが ヶヰヴ 
Wｷｪｪゲ MPが W;ゲｴｷﾐｪデﾗﾐ TAが ;ﾐS GヴWWﾐW NPく MｷデﾗIｴﾗﾐSヴｷ;ﾉ SWｪWﾐWヴ;デｷﾗﾐ ヮヴWIWSWゲ デｴW SW┗WﾉﾗヮﾏWﾐデ ﾗa ﾏ┌ゲIﾉW ;デヴﾗヮｴ┞ ヶヰヵ 
ｷﾐ ヮヴﾗｪヴWゲゲｷﾗﾐ ﾗa I;ﾐIWヴ I;IｴW┝ｷ; ｷﾐ デ┌ﾏﾗ┌ヴどHW;ヴｷﾐｪ ﾏｷIWく J C;IｴW┝ｷ; S;ヴIﾗヮWﾐｷ; M┌ゲIﾉW Βぎ ΓヲヶどΓンΒが ヲヰヱΑく ヶヰヶ 
ヱヱく B┌ヴデゲIｴWヴ Jが Z;ﾐｪヴ;ﾐSｷ Lが SIｴ┘;ヴ┣Wヴ Cが ;ﾐS Gﾐ;ｷｪWヴ Eく DｷaaWヴWﾐIWゲ ｷﾐ ﾏｷデﾗIｴﾗﾐSヴｷ;ﾉ a┌ﾐIデｷﾗﾐ ｷﾐ ｴﾗﾏﾗｪWﾐ;デWS ヶヰΑ 
ゲ;ﾏヮﾉWゲ aヴﾗﾏ ｴW;ﾉデｴ┞ ;ﾐS WヮｷﾉWヮデｷI ゲヮWIｷaｷI Hヴ;ｷﾐ デｷゲゲ┌Wゲ ヴW┗W;ﾉWS H┞ ｴｷｪｴどヴWゲﾗﾉ┌デｷﾗﾐ ヴWゲヮｷヴﾗﾏWデヴ┞く MｷデﾗIｴﾗﾐSヴｷﾗﾐ ヲヵぎ ヶヰΒ 
ヱヰヴどヱヱヲが ヲヰヱヵく ヶヰΓ 
ヱヲく C;ﾐデﾗ Cが ;ﾐS G;ヴIｷ;どRﾗ┗Wゲ PMく HｷｪｴどRWゲﾗﾉ┌デｷﾗﾐ RWゲヮｷヴﾗﾏWデヴ┞ aﾗヴ MｷデﾗIｴﾗﾐSヴｷ;ﾉ Cｴ;ヴ;IデWヴｷ┣;デｷﾗﾐ ﾗa E┝ Vｷ┗ﾗ ヶヱヰ 
Mﾗ┌ゲW Tｷゲゲ┌Wゲく C┌ヴヴ PヴﾗデﾗI Mﾗ┌ゲW Bｷﾗﾉ ヵぎ ヱンヵどヱヵンが ヲヰヱヵく ヶヱヱ 
ヱンく C;ヴゲﾗﾐ JAが H;ヴSWW JPが ;ﾐS V;ﾐSWヴVWWﾐ BNく TｴW WﾏWヴｪｷﾐｪ ヴﾗﾉW ﾗa ゲﾆWﾉWデ;ﾉ ﾏ┌ゲIﾉW ﾗ┝ｷS;デｷ┗W ﾏWデ;Hﾗﾉｷゲﾏ ;ゲ ; ヶヱヲ 
HｷﾗﾉﾗｪｷI;ﾉ デ;ヴｪWデ ;ﾐS IWﾉﾉ┌ﾉ;ヴ ヴWｪ┌ﾉ;デﾗヴ ﾗa I;ﾐIWヴどｷﾐS┌IWS ﾏ┌ゲIﾉW ┘;ゲデｷﾐｪく SWﾏｷﾐ CWﾉﾉ DW┗ Bｷﾗﾉ ヵヴぎ ヵンどヶΑが ヲヰヱヶく ヶヱン 
ヱヴく CｴｷIIﾗ AJが LW CHが SIｴﾉ;デWヴ Aが Nｪ┌┞Wﾐ Aが K;┞W Sが BW;ﾉゲ JWが SI;ﾉ┣ﾗ RLが BWﾉﾉ Cが Gﾐ;ｷｪWヴ Eが Cﾗゲデ; DPが CヴﾗIﾆWヴ DEが ヶヱヴ 
;ﾐS K;ﾐ;デﾗ┌ゲ SBく Hｷｪｴ a;デデ┞ ;IｷS ﾗ┝ｷS;デｷﾗﾐ I;ヮ;Iｷデ┞ ;ﾐS ヮｴﾗゲヮｴﾗヴ┞ﾉ;デｷﾗﾐ Iﾗﾐデヴﾗﾉ SWゲヮｷデW WﾉW┗;デWS ﾉW;ﾆ ;ﾐS ヴWS┌IWS ヶヱヵ 
ヴWゲヮｷヴ;デﾗヴ┞ I;ヮ;Iｷデ┞ ｷﾐ ﾐﾗヴデｴWヴﾐ WﾉWヮｴ;ﾐデ ゲW;ﾉ ﾏ┌ゲIﾉW ﾏｷデﾗIｴﾗﾐSヴｷ;く J E┝ヮ Bｷﾗﾉ ヲヱΑぎ ヲΓヴΑどヲΓヵヵが ヲヰヱヴく ヶヱヶ 
ヱヵく CｴｷIIﾗ AJが ;ﾐS Sヮ;ヴ;ｪﾐ; GCく RﾗﾉW ﾗa I;ヴSｷﾗﾉｷヮｷﾐ ;ﾉデWヴ;デｷﾗﾐゲ ｷﾐ ﾏｷデﾗIｴﾗﾐSヴｷ;ﾉ S┞ゲa┌ﾐIデｷﾗﾐ ;ﾐS SｷゲW;ゲWく Aﾏ J ヶヱΑ 
Pｴ┞ゲｷﾗﾉ CWﾉﾉ Pｴ┞ゲｷﾗﾉ ヲΓヲぎ Cンンどヴヴが ヲヰヰΑく ヶヱΒ 
ヱヶく Cﾗﾐゲデ;ﾐデｷﾐﾗ┌ Cが FﾗﾐデWゲ SW Oﾉｷ┗Wｷヴ; CCが Mｷﾐデ┣ﾗヮﾗ┌ﾉﾗゲ Dが B┌ゲケ┌Wデゲ Sが HW Jが KWゲ;ヴ┘;ﾐｷ Mが MｷﾐSヴｷﾐﾗゲ Mが R;ｴﾏW ヶヱΓ 
LGが AヴｪｷﾉWゲ JMが ;ﾐS T┣ｷﾆ; AAく N┌IﾉW;ヴ ﾏ;ｪﾐWデｷI ヴWゲﾗﾐ;ﾐIW ｷﾐ Iﾗﾐﾃ┌ﾐIデｷﾗﾐ ┘ｷデｴ a┌ﾐIデｷﾗﾐ;ﾉ ｪWﾐﾗﾏｷIゲ ゲ┌ｪｪWゲデゲ ヶヲヰ 
ﾏｷデﾗIｴﾗﾐSヴｷ;ﾉ S┞ゲa┌ﾐIデｷﾗﾐ ｷﾐ ; ﾏ┌ヴｷﾐW ﾏﾗSWﾉ ﾗa I;ﾐIWヴ I;IｴW┝ｷ;く IﾐデWヴﾐ;デｷﾗﾐ;ﾉ ﾃﾗ┌ヴﾐ;ﾉ ﾗa ﾏﾗﾉWI┌ﾉ;ヴ ﾏWSｷIｷﾐW ヲΑぎ ヱヵどヲヴが ヶヲヱ 
ヲヰヱヱく ヶヲヲ 
ヱΑく D;ｴﾉﾏ;ﾐ Iが MWﾃｴWヴデ Nが LｷﾐSWヴ Kが Aｪ┌ゲデゲゲﾗﾐ Tが M┌デIｴ DMが K┌ﾉ┞デW Aが Iゲ;ﾆゲゲﾗﾐ Bが PWヴﾏWヴデ Jが PWデヴﾗ┗ｷI Nが ヶヲン 
NWSWヴｪ;;ヴS Jが Sﾃﾗﾉｷﾐ Eが BヴﾗSｷﾐ Dが CﾉWﾏWﾐデ Kが D;ｴﾉﾏ;ﾐどWヴｷｪｴデ Kが R┞SWﾐ Mが ;ﾐS AヴﾐWヴ Pく ASｷヮﾗゲW デｷゲゲ┌W ヮ;デｴ┘;┞ゲ ヶヲヴ 
ｷﾐ┗ﾗﾉ┗WS ｷﾐ ┘Wｷｪｴデ ﾉﾗゲゲ ﾗa I;ﾐIWヴ I;IｴW┝ｷ;く Bヴ J C;ﾐIWヴ ヱヰヲぎ ヱヵヴヱどヱヵヴΒが ヲヰヱヰく ヶヲヵ 
ヱΒく Dｷ M;ヴIﾗ Sが C;ﾏﾏ;ゲ Aが Lｷ;ﾐ XJが Kﾗ┗;Iゲ ENが M; JFが H;ﾉﾉ DTが M;┣ヴﾗ┌ｷ Rが RｷIｴ;ヴSゲﾗﾐ Jが PWﾉﾉWデｷWヴ Jが ;ﾐS G;ﾉﾉﾗ┌┣ｷ IEく ヶヲヶ 
TｴW デヴ;ﾐゲﾉ;デｷﾗﾐ ｷﾐｴｷHｷデﾗヴ ヮ;デW;ﾏｷﾐW A ヮヴW┗Wﾐデゲ I;IｴW┝ｷ;どｷﾐS┌IWS ﾏ┌ゲIﾉW ┘;ゲデｷﾐｪ ｷﾐ ﾏｷIWく N;デ Cﾗﾏﾏ┌ﾐ ンぎ ΒΓヶが ヲヰヱヲく ヶヲΑ 
ヱΓく DｷaaWW GMが K;ﾉa;ゲ Kが AﾉどM;ﾃｷS Sが ;ﾐS MIC;ヴデｴ┞ DOく AﾉデWヴWS W┝ヮヴWゲゲｷﾗﾐ ﾗa ゲﾆWﾉWデ;ﾉ ﾏ┌ゲIﾉW ﾏ┞ﾗゲｷﾐ ｷゲﾗaﾗヴﾏゲ ｷﾐ ヶヲΒ 
I;ﾐIWヴ I;IｴW┝ｷ;く Aﾏ J Pｴ┞ゲｷﾗﾉ CWﾉﾉ Pｴ┞ゲｷﾗﾉ ヲΒンぎ CヱンΑヶどヱンΒヲが ヲヰヰヲく ヶヲΓ 
ヲヰく D┌ﾏ;ゲ JFが Gﾗ┌ヮｷﾉﾉW Cが J┌ﾉｷWﾐﾐW CMが Pｷﾐ;┌ﾉデ Mが CｴW┗;ﾉｷWヴ Sが Bﾗ┌ｪﾐﾗ┌┝ Pが SWヴ┗;ｷゲ Sが ;ﾐS Cﾗ┌Wデ Cく EaaｷIｷWﾐI┞ ﾗa ヶンヰ 
ﾗ┝ｷS;デｷ┗W ヮｴﾗゲヮｴﾗヴ┞ﾉ;デｷﾗﾐ ｷﾐ ﾉｷ┗Wヴ ﾏｷデﾗIｴﾗﾐSヴｷ; ｷゲ SWIヴW;ゲWS ｷﾐ ; ヴ;デ ﾏﾗSWﾉ ﾗa ヮWヴｷデﾗﾐW;ﾉ I;ヴIｷﾐﾗゲｷゲく J HWヮ;デﾗﾉ ヵヴぎ ンヲヰどヶンヱ 
ンヲΑが ヲヰヱヱく ヶンヲ 
ヲヱく D┌ﾏ;ゲ JFが PW┞デ; Lが Cﾗ┌Wデ Cが ;ﾐS SWヴ┗;ｷゲ Sく IﾏヮﾉｷI;デｷﾗﾐ ﾗa ﾉｷ┗Wヴ I;ヴSｷﾗﾉｷヮｷﾐゲ ｷﾐ ﾏｷデﾗIｴﾗﾐSヴｷ;ﾉ WﾐWヴｪ┞ ﾏWデ;Hﾗﾉｷゲﾏ ヶンン 
SｷゲﾗヴSWヴ ｷﾐ I;ﾐIWヴ I;IｴW┝ｷ;く BｷﾗIｴｷﾏｷW Γヵぎ ヲΑどンヲが ヲヰヱンく ヶンヴ 
ヲン 
 
ヲヲく FW;ヴﾗﾐ Kが AヴWﾐSゲ Jが ;ﾐS B;ヴ;Iﾗゲ Vく UﾐSWヴゲデ;ﾐSｷﾐｪ デｴW ﾏWIｴ;ﾐｷゲﾏゲ ;ﾐS デヴW;デﾏWﾐデ ﾗヮデｷﾗﾐゲ ｷﾐ I;ﾐIWヴ I;IｴW┝ｷ;く ヶンヵ 
N;デ RW┗ Cﾉｷﾐ OﾐIﾗﾉ ヱヰぎ ΓヰどΓΓが ヲヰヱンく ヶンヶ 
ヲンく FWヴﾏﾗゲWﾉﾉW Cが G;ヴIｷ;どAヴ┌ﾏｷ Eが P┌ｷｪどVｷﾉ;ﾐﾗ┗; Eが AﾐSヴW┌ ALが UヴデヴWｪWヴ AJが SW KｷWヴ JﾗaaW EDが TWﾃWSﾗヴ Aが P┌WﾐデWどヶンΑ 
M;Wゲデ┌ Lが ;ﾐS B;ヴヴWｷヴﾗ Eく MｷデﾗIｴﾗﾐSヴｷ;ﾉ S┞ゲa┌ﾐIデｷﾗﾐ ;ﾐS デｴWヴ;ヮW┌デｷI ;ヮヮヴﾗ;IｴWゲ ｷﾐ ヴWゲヮｷヴ;デﾗヴ┞ ;ﾐS ﾉｷﾏH ﾏ┌ゲIﾉWゲ ﾗa ヶンΒ 
I;ﾐIWヴ I;IｴWIデｷI ﾏｷIWく E┝ヮ Pｴ┞ゲｷﾗﾉ ΓΒぎ ヱンヴΓどヱンヶヵが ヲヰヱンく ヶンΓ 
ヲヴく G;ﾉﾉWデ PFが M;aデ;ｴ Aが PWデｷデ JMが DWﾐｷゲどG;┞ Mが ;ﾐS J┌ﾉｷWﾐ Rく DｷヴWIデ I;ヴSｷﾗﾉｷヮｷﾐ ;ゲゲ;┞ ｷﾐ ┞W;ゲデ ┌ゲｷﾐｪ デｴW ヴWS ヶヴヰ 
aﾉ┌ﾗヴWゲIWﾐIW Wﾏｷゲゲｷﾗﾐ ﾗa ヱヰどNどﾐﾗﾐ┞ﾉ ;IヴｷSｷﾐW ﾗヴ;ﾐｪWく E┌ヴ J BｷﾗIｴWﾏ ヲヲΒぎ ヱヱンどヱヱΓが ヱΓΓヵく ヶヴヱ 
ヲヵく G;ヴIｷ; FWヴﾐ;ﾐSW┣ MIが CWII;ヴWﾉﾉｷ Dが ;ﾐS M┌ゲI;デWﾉﾉﾗ Uく UゲW ﾗa デｴW aﾉ┌ﾗヴWゲIWﾐデ S┞W ヱヰどNどﾐﾗﾐ┞ﾉ ;IヴｷSｷﾐW ﾗヴ;ﾐｪW ｷﾐ ヶヴヲ 
ケ┌;ﾐデｷデ;デｷ┗W ;ﾐS ﾉﾗI;デｷﾗﾐ ;ゲゲ;┞ゲ ﾗa I;ヴSｷﾗﾉｷヮｷﾐぎ ; ゲデ┌S┞ ﾗﾐ SｷaaWヴWﾐデ W┝ヮWヴｷﾏWﾐデ;ﾉ ﾏﾗSWﾉゲく Aﾐ;ﾉ BｷﾗIｴWﾏ ンヲΒぎ ヱΑヴどヱΒヰが ヶヴン 
ヲヰヰヴく ヶヴヴ 
ヲヶく Gﾐ;ｷｪWヴ Eく C;ヮ;Iｷデ┞ ﾗa ﾗ┝ｷS;デｷ┗W ヮｴﾗゲヮｴﾗヴ┞ﾉ;デｷﾗﾐ ｷﾐ ｴ┌ﾏ;ﾐ ゲﾆWﾉWデ;ﾉ ﾏ┌ゲIﾉWぎ ﾐW┘ ヮWヴゲヮWIデｷ┗Wゲ ﾗa ﾏｷデﾗIｴﾗﾐSヴｷ;ﾉ ヶヴヵ 
ヮｴ┞ゲｷﾗﾉﾗｪ┞く Iﾐデ J BｷﾗIｴWﾏ CWﾉﾉ Bｷﾗﾉ ヴヱぎ ヱΒンΑどヱΒヴヵが ヲヰヰΓく ヶヴヶ 
ヲΑく GﾗﾐI;ﾉ┗Wゲ MDが H┘;ﾐｪ SKが P;┌ﾉｷ Cが M┌ヴヮｴ┞ CJが CｴWﾐｪ Zが Hﾗヮﾆｷﾐゲ BDが W┌ Dが Lﾗ┌ｪｴヴ;ﾐ RMが EﾏWヴﾉｷﾐｪ BMが Zｴ;ﾐｪ ヶヴΑ 
Gが FW;ヴﾗﾐ DTが ;ﾐS C;ﾐデﾉW┞ LCく FWﾐﾗaｷHヴ;デW ヮヴW┗Wﾐデゲ ゲﾆWﾉWデ;ﾉ ﾏ┌ゲIﾉW ﾉﾗゲゲ ｷﾐ ﾏｷIW ┘ｷデｴ ﾉ┌ﾐｪ I;ﾐIWヴく PヴﾗI N;デﾉ AI;S SIｷ U S ヶヴΒ 
A ヱヱヵぎ EΑヴンどEΑヵヲが ヲヰヱΒく ヶヴΓ 
ヲΒく HWｷﾏ ABが Cｴ┌ﾐｪ Dが Fﾉﾗヴ;ﾐデ GLが ;ﾐS CｴｷIIﾗ AJく Tｷゲゲ┌WどゲヮWIｷaｷI ゲW;ゲﾗﾐ;ﾉ Iｴ;ﾐｪWゲ ｷﾐ ﾏｷデﾗIｴﾗﾐSヴｷ;ﾉ a┌ﾐIデｷﾗﾐ ﾗa ; ヶヵヰ 
ﾏ;ﾏﾏ;ﾉｷ;ﾐ ｴｷHWヴﾐ;デﾗヴく Aﾏ J Pｴ┞ゲｷﾗﾉ RWｪ┌ﾉ IﾐデWｪヴ Cﾗﾏヮ Pｴ┞ゲｷﾗﾉ ンヱンぎ RヱΒヰどRヱΓヰが ヲヰヱΑく ヶヵヱ 
ヲΓく HﾗWﾆゲ Jが ┗;ﾐ HWヴヮWﾐ NAが MWﾐゲｷﾐﾆ Mが MﾗﾗﾐWﾐどKﾗヴﾐｷヮゲ Eが ┗;ﾐ BW┌ヴSWﾐ Dが HWゲゲWﾉｷﾐﾆ MKが ;ﾐS SIｴヴ;┌┘Wﾐ Pく ヶヵヲ 
PヴﾗﾉﾗﾐｪWS a;ゲデｷﾐｪ ｷSWﾐデｷaｷWゲ ゲﾆWﾉWデ;ﾉ ﾏ┌ゲIﾉW ﾏｷデﾗIｴﾗﾐSヴｷ;ﾉ S┞ゲa┌ﾐIデｷﾗﾐ ;ゲ IﾗﾐゲWケ┌WﾐIW ヴ;デｴWヴ デｴ;ﾐ I;┌ゲW ﾗa ｴ┌ﾏ;ﾐ ヶヵン 
ｷﾐゲ┌ﾉｷﾐ ヴWゲｷゲデ;ﾐIWく Dｷ;HWデWゲ ヵΓぎ ヲヱヱΑどヲヱヲヵが ヲヰヱヰく ヶヵヴ 
ンヰく Iﾐ;ｪ;ﾆｷ Jが RﾗSヴｷｪ┌W┣ Vが ;ﾐS BﾗSW┞ GPく PヴﾗIWWSｷﾐｪゲぎ C;┌ゲWゲ ﾗa SW;デｴ ｷﾐ I;ﾐIWヴ ヮ;デｷWﾐデゲく C;ﾐIWヴ ンンぎ ヵヶΒどヵΑンが ヶヵヵ 
ヱΓΑヴく ヶヵヶ 
ンヱく J┌ﾉｷWﾐﾐW CMが D┌ﾏ;ゲ JFが Gﾗ┌ヮｷﾉﾉW Cが Pｷﾐ;┌ﾉデ Mが BWヴヴｷ Cが Cﾗﾉﾉｷﾐ Aが TWゲゲWヴ;┌S Sが Cﾗ┌Wデ Cが ;ﾐS SWヴ┗;ｷゲ Sく C;ﾐIWヴ ヶヵΑ 
I;IｴW┝ｷ; ｷゲ ;ゲゲﾗIｷ;デWS ┘ｷデｴ ; SWIヴW;ゲW ｷﾐ ゲﾆWﾉWデ;ﾉ ﾏ┌ゲIﾉW ﾏｷデﾗIｴﾗﾐSヴｷ;ﾉ ﾗ┝ｷS;デｷ┗W I;ヮ;IｷデｷWゲ ┘ｷデｴﾗ┌デ ;ﾉデWヴ;デｷﾗﾐ ﾗa ATP ヶヵΒ 
ヮヴﾗS┌Iデｷﾗﾐ WaaｷIｷWﾐI┞く J C;IｴW┝ｷ; S;ヴIﾗヮWﾐｷ; M┌ゲIﾉW ンぎ ヲヶヵどヲΑヵが ヲヰヱヲく ヶヵΓ 
ンヲく J┌ﾉｷWﾐﾐW CMが T;ヴSｷW┌ Mが CｴW┗;ﾉｷWヴ Sが Pｷﾐ;┌ﾉデ Mが Bﾗ┌ｪﾐﾗ┌┝ Pが L;H;ヴデｴW Fが Cﾗ┌Wデ Cが SWヴ┗;ｷゲ Sが ;ﾐS D┌ﾏ;ゲ JFく ヶヶヰ 
C;ヴSｷﾗﾉｷヮｷﾐ IﾗﾐデWﾐデ ｷゲ ｷﾐ┗ﾗﾉ┗WS ｷﾐ ﾉｷ┗Wヴ ﾏｷデﾗIｴﾗﾐSヴｷ;ﾉ WﾐWヴｪ┞ ┘;ゲデｷﾐｪ ;ゲゲﾗIｷ;デWS ┘ｷデｴ I;ﾐIWヴどｷﾐS┌IWS I;IｴW┝ｷ; ┘ｷデｴﾗ┌デ ヶヶヱ 
デｴW ｷﾐ┗ﾗﾉ┗WﾏWﾐデ ﾗa ;SWﾐｷﾐW ﾐ┌IﾉWﾗデｷSW デヴ;ﾐゲﾉﾗI;ゲWく BｷﾗIｴｷﾏ Bｷﾗヮｴ┞ゲ AIデ; ヱΒヴヲぎ ΑヲヶどΑンンが ヲヰヱヴく ヶヶヲ 
ンンく Kｴ;ﾏﾗ┌ｷ AVが P;ヴﾆ BSが Kｷﾏ DHが YWｴ MCが Oｴ SLが Eﾉ;ﾏ MLが Jﾗ Eが Aヴﾃﾏ;ﾐSｷ BHが S;ﾉ;┣;ヴ Gが Gヴ;ﾐデ SCが CﾗﾐデヴWヴ;ゲ RJが ヶヶン 
LWW WJが ;ﾐS Kｷﾏ JSく AWヴﾗHｷI ;ﾐS ヴWゲｷゲデ;ﾐIW デヴ;ｷﾐｷﾐｪ SWヮWﾐSWﾐデ ゲﾆWﾉWデ;ﾉ ﾏ┌ゲIﾉW ヮﾉ;ゲデｷIｷデ┞ ｷﾐ デｴW Iﾗﾉﾗﾐどヲヶ ﾏ┌ヴｷﾐW ﾏﾗSWﾉ ヶヶヴ 
ﾗa I;ﾐIWヴ I;IｴW┝ｷ;く MWデ;Hﾗﾉｷゲﾏ ヶヵぎ ヶΒヵどヶΓΒが ヲヰヱヶく ヶヶヵ 
ンヴく Kｷヴ Sが Kﾗﾏ;H; Hが G;ヴIｷ; APが EIﾗﾐﾗﾏﾗヮﾗ┌ﾉﾗゲ KPが Lｷ┌ Wが L;ﾐゲﾆW Bが HﾗSｷﾐ RAが ;ﾐS SヮｷWｪWﾉﾏ;ﾐ BMく PTHっPTHヴP ヶヶヶ 
RWIWヮデﾗヴ MWSｷ;デWゲ C;IｴW┝ｷ; ｷﾐ MﾗSWﾉゲ ﾗa KｷSﾐW┞ F;ｷﾉ┌ヴW ;ﾐS C;ﾐIWヴく CWﾉﾉ MWデ;H ヲンぎ ンヱヵどンヲンが ヲヰヱヶく ヶヶΑ 
ンヵく Kｷヴ Sが WｴｷデW JPが KﾉWｷﾐWヴ Sが K;┣;ﾆ Lが CﾗｴWﾐ Pが B;ヴ;Iﾗゲ VEが ;ﾐS SヮｷWｪWﾉﾏ;ﾐ BMく T┌ﾏﾗ┌ヴどSWヴｷ┗WS PTHどヴWﾉ;デWS ヶヶΒ 
ヮヴﾗデWｷﾐ デヴｷｪｪWヴゲ ;SｷヮﾗゲW デｷゲゲ┌W Hヴﾗ┘ﾐｷﾐｪ ;ﾐS I;ﾐIWヴ I;IｴW┝ｷ;く N;デ┌ヴW ヵヱンぎ ヱヰヰどヱヰヴが ヲヰヱヴく ヶヶΓ 
ンヶく K┌┣ﾐWデゲﾗ┗ AVが SデヴﾗHﾉ Dが R┌デデﾏ;ﾐﾐ Eが Kﾗﾐｷｪゲヴ;ｷﾐWヴ Aが M;ヴｪヴWｷデWヴ Rが ;ﾐS Gﾐ;ｷｪWヴ Eく E┗;ﾉ┌;デｷﾗﾐ ﾗa ﾏｷデﾗIｴﾗﾐSヴｷ;ﾉ ヶΑヰ 
ヴWゲヮｷヴ;デﾗヴ┞ a┌ﾐIデｷﾗﾐ ｷﾐ ゲﾏ;ﾉﾉ HｷﾗヮゲｷWゲ ﾗa ﾉｷ┗Wヴく Aﾐ;ﾉ BｷﾗIｴWﾏ ンヰヵぎ ヱΒヶどヱΓヴが ヲヰヰヲく ヶΑヱ 
ンΑく K┌┣ﾐWデゲﾗ┗ AVが VWﾆゲﾉWヴ Vが GWﾉﾉWヴｷIｴ FNが S;ﾆゲ Vが M;ヴｪヴWｷデWヴ Rが ;ﾐS K┌ﾐ┣ WSく Aﾐ;ﾉ┞ゲｷゲ ﾗa ﾏｷデﾗIｴﾗﾐSヴｷ;ﾉ a┌ﾐIデｷﾗﾐ ｷﾐ ヶΑヲ 
ゲｷデ┌ ｷﾐ ヮWヴﾏW;Hｷﾉｷ┣WS ﾏ┌ゲIﾉW aｷHWヴゲが デｷゲゲ┌Wゲ ;ﾐS IWﾉﾉゲく N;デ PヴﾗデﾗI ンぎ ΓヶヵどΓΑヶが ヲヰヰΒく ヶΑン 
ンΒく L;ﾐデｷWヴ Lが Wｷﾉﾉｷ;ﾏゲ ASが Wｷﾉﾉｷ;ﾏゲ IMが Y;ﾐｪ KKが Bヴ;I┞ DPが GﾗWﾉ┣Wヴ Mが J;ﾏWゲ FDが Gｷ┌ゲ Dが ;ﾐS W;ゲゲWヴﾏ;ﾐ DHく ヶΑヴ 
SIRTン Iゲ Cヴ┌Iｷ;ﾉ aﾗヴ M;ｷﾐデ;ｷﾐｷﾐｪ SﾆWﾉWデ;ﾉ M┌ゲIﾉW Iﾐゲ┌ﾉｷﾐ AIデｷﾗﾐ ;ﾐS PヴﾗデWIデゲ Aｪ;ｷﾐゲデ SW┗WヴW Iﾐゲ┌ﾉｷﾐ RWゲｷゲデ;ﾐIW ｷﾐ HｷｪｴどF;デどヶΑヵ 
FWS MｷIWく Dｷ;HWデWゲ ヶヴぎ ンヰΒヱどンヰΓヲが ヲヰヱヵく ヶΑヶ 
ンΓく MILW;ﾐ JBが Mﾗ┞ﾉ;ﾐ JSが ;ﾐS AﾐSヴ;SW FHく MｷデﾗIｴﾗﾐSヴｷ; S┞ゲa┌ﾐIデｷﾗﾐ ｷﾐ ﾉ┌ﾐｪ I;ﾐIWヴどｷﾐS┌IWS ﾏ┌ゲIﾉW ┘;ゲデｷﾐｪ ｷﾐ ヶΑΑ 
CヲCヱヲ ﾏ┞ﾗデ┌HWゲく Fヴﾗﾐデ Pｴ┞ゲｷﾗﾉ ヵぎ ヵヰンが ヲヰヱヴく ヶΑΒ 
ヴヰく Mｷゲｴヴ; Pが ;ﾐS Cｴ;ﾐ DCく MWデ;HﾗﾉｷI ヴWｪ┌ﾉ;デｷﾗﾐ ﾗa ﾏｷデﾗIｴﾗﾐSヴｷ;ﾉ S┞ﾐ;ﾏｷIゲく J CWﾉﾉ Bｷﾗﾉ ヲヱヲぎ ンΑΓどンΒΑが ヲヰヱヶく ヶΑΓ 
ヴヱく Mﾗヴヴﾗ┘ RMが PｷI;ヴS Mが DWヴHWﾐW┗; Oが LWｷヮ┣ｷｪ Jが MIM;ﾐ┌ゲ MJが Gﾗ┌ゲヮｷﾉﾉﾗ┌ Gが B;ヴH;デどAヴデｷｪ;ゲ Sが Dﾗゲ S;ﾐデﾗゲ Cが ヶΒヰ 
HWヮヮﾉW RTが M┌ヴSﾗIﾆ DGが ;ﾐS W;ﾉﾉ;IW DCく MｷデﾗIｴﾗﾐSヴｷ;ﾉ WﾐWヴｪ┞ SWaｷIｷWﾐI┞ ﾉW;Sゲ デﾗ ｴ┞ヮWヴヮヴﾗﾉｷaWヴ;デｷﾗﾐ ﾗa ゲﾆWﾉWデ;ﾉ ヶΒヱ 
ﾏ┌ゲIﾉW ﾏｷデﾗIｴﾗﾐSヴｷ; ;ﾐS Wﾐｴ;ﾐIWS ｷﾐゲ┌ﾉｷﾐ ゲWﾐゲｷデｷ┗ｷデ┞く PヴﾗI N;デﾉ AI;S SIｷ U S A ヱヱヴぎ ヲΑヰヵどヲΑヱヰが ヲヰヱΑく ヶΒヲ 
ヴヲく M┌ヴヮｴ┞ KTが CｴWW Aが TヴｷW┌ Jが N;ｷﾏ Tが ;ﾐS L┞ﾐIｴ GSく Iﾏヮﾗヴデ;ﾐIW ﾗa a┌ﾐIデｷﾗﾐ;ﾉ ;ﾐS ﾏWデ;HﾗﾉｷI ｷﾏヮ;ｷヴﾏWﾐデゲ ｷﾐ デｴW ヶΒン 
Iｴ;ヴ;IデWヴｷ┣;デｷﾗﾐ ﾗa デｴW Cどヲヶ ﾏ┌ヴｷﾐW ﾏﾗSWﾉ ﾗa I;ﾐIWヴ I;IｴW┝ｷ;く DｷゲW;ゲW ﾏﾗSWﾉゲ わ ﾏWIｴ;ﾐｷゲﾏゲ ヵぎ ヵンンどヵヴヵが ヲヰヱヲく ヶΒヴ 
ヴンく PWゲデ; Dが ;ﾐS Gﾐ;ｷｪWヴ Eく HｷｪｴどヴWゲﾗﾉ┌デｷﾗﾐ ヴWゲヮｷヴﾗﾏWデヴ┞ぎ OXPHOS ヮヴﾗデﾗIﾗﾉゲ aﾗヴ ｴ┌ﾏ;ﾐ IWﾉﾉゲ ;ﾐS ヮWヴﾏW;Hｷﾉｷ┣WS ヶΒヵ 
aｷHWヴゲ aヴﾗﾏ ゲﾏ;ﾉﾉ HｷﾗヮゲｷWゲ ﾗa ｴ┌ﾏ;ﾐ ﾏ┌ゲIﾉWく MWデｴﾗSゲ Mﾗﾉ Bｷﾗﾉ Βヱヰぎ ヲヵどヵΒが ヲヰヱヲく ヶΒヶ 
ヲヴ 
 
ヴヴく PWデヴ┌┣┣Wﾉﾉｷ Mが SIｴ┘WｷｪWヴ Mが SIｴヴWｷHWヴ Rが C;ﾏヮﾗゲどOﾉｷ┗;ゲ Rが Tゲﾗﾉｷ Mが AﾉﾉWﾐ Jが S┘;ヴHヴｷIﾆ Mが RﾗゲWどJﾗｴﾐ Sが RｷﾐIﾗﾐ ヶΒΑ 
Mが RﾗHWヴデゲﾗﾐ Gが ZWIｴﾐWヴ Rが ;ﾐS W;ｪﾐWヴ EFく A ゲ┘ｷデIｴ aヴﾗﾏ ┘ｴｷデW デﾗ Hヴﾗ┘ﾐ a;デ ｷﾐIヴW;ゲWゲ WﾐWヴｪ┞ W┝ヮWﾐSｷデ┌ヴW ｷﾐ I;ﾐIWヴどヶΒΒ 
;ゲゲﾗIｷ;デWS I;IｴW┝ｷ;く CWﾉﾉ MWデ;H ヲヰぎ ヴンンどヴヴΑが ヲヰヱヴく ヶΒΓ 
ヴヵく PWデヴ┌┣┣Wﾉﾉｷ Mが ;ﾐS W;ｪﾐWヴ EFく MWIｴ;ﾐｷゲﾏゲ ﾗa ﾏWデ;HﾗﾉｷI S┞ゲa┌ﾐIデｷﾗﾐ ｷﾐ I;ﾐIWヴど;ゲゲﾗIｷ;デWS I;IｴW┝ｷ;く GWﾐWゲ DW┗ ヶΓヰ 
ンヰぎ ヴΒΓどヵヰヱが ヲヰヱヶく ヶΓヱ 
ヴヶく Pﾗヴヮﾗヴ;デﾗ PEく UﾐSWヴゲデ;ﾐSｷﾐｪ I;IｴW┝ｷ; ;ゲ ; I;ﾐIWヴ ﾏWデ;Hﾗﾉｷゲﾏ ゲ┞ﾐSヴﾗﾏWく OﾐIﾗｪWﾐWゲｷゲ ヵぎ Wヲヰヰが ヲヰヱヶく ヶΓヲ 
ヴΑく PﾗヴデWヴ Cが HWヴﾐSﾗﾐ DNが CｴﾗﾐSヴﾗﾐｷﾆﾗﾉ; Mが Cｴ;ﾗ Tが Aﾐﾐ;ﾏ;ﾉ;ｷ Pが Bｴ;デデ;ヴ;ｷ Nが S;ヴ;a MKが C;ヮWﾆ KDが RWｷS┞ PTが ヶΓン 
D;ケ┌ｷﾐ;ｪ ACが Kﾗﾉﾗﾐｷﾐ MGが R;ゲﾏ┌ゲゲWﾐ BBが BﾗヴゲｴWｷﾏ Eが Tﾗﾉｷ┗WヴどKｷﾐゲﾆ┞ Tが ;ﾐS SｷSﾗゲゲｷゲ LSく H┌ﾏ;ﾐ ;ﾐS Mﾗ┌ゲW Bヴﾗ┘ﾐ ヶΓヴ 
ASｷヮﾗゲW Tｷゲゲ┌W MｷデﾗIｴﾗﾐSヴｷ; H;┗W Cﾗﾏヮ;ヴ;HﾉW UCPヱ F┌ﾐIデｷﾗﾐく CWﾉﾉ MWデ;H ヲヴぎ ヲヴヶどヲヵヵが ヲヰヱヶく ヶΓヵ 
ヴΒく PﾗヴデWヴ Cが H┌ヴヴWﾐ NMが CﾗデデWヴ MVが Bｴ;デデ;ヴ;ｷ Nが RWｷS┞ PTが Dｷﾉﾉﾗﾐ ELが D┌ヴｴ;ﾏ WJが T┌┗SWﾐSﾗヴﾃ Dが SｴWaaｷWﾉSどMﾗﾗヴW ヶΓヶ 
Mが Vﾗﾉヮｷ Eが SｷSﾗゲゲｷゲ LSが R;ゲﾏ┌ゲゲWﾐ BBが ;ﾐS BﾗヴゲｴWｷﾏ Eく MｷデﾗIｴﾗﾐSヴｷ;ﾉ ヴWゲヮｷヴ;デﾗヴ┞ I;ヮ;Iｷデ┞ ;ﾐS Iﾗ┌ヮﾉｷﾐｪ Iﾗﾐデヴﾗﾉ SWIﾉｷﾐW ヶΓΑ 
┘ｷデｴ ;ｪW ｷﾐ ｴ┌ﾏ;ﾐ ゲﾆWﾉWデ;ﾉ ﾏ┌ゲIﾉWく Aﾏ J Pｴ┞ゲｷﾗﾉ EﾐSﾗIヴｷﾐﾗﾉ MWデ;H ンヰΓぎ Eヲヲヴどヲンヲが ヲヰヱヵく ヶΓΒ 
ヴΓく R;ﾐ; Aが Oﾉｷ┗Wｷヴ; MPが Kｴ;ﾏﾗ┌ｷ AVが Aヮ;ヴｷIｷﾗ Rが RWヴ; Mが RﾗゲゲｷデWヴ HBが ;ﾐS W;ﾉﾆWヴ DWく Pヴﾗﾏﾗデｷﾐｪ DヴヮヱどﾏWSｷ;デWS ヶΓΓ 
ﾏｷデﾗIｴﾗﾐSヴｷ;ﾉ aｷゲゲｷﾗﾐ ｷﾐ ﾏｷSﾉｷaW ヮヴﾗﾉﾗﾐｪゲ ｴW;ﾉデｴ┞ ﾉｷaWゲヮ;ﾐ ﾗa Dヴﾗゲﾗヮｴｷﾉ; ﾏWﾉ;ﾐﾗｪ;ゲデWヴく N;デ Cﾗﾏﾏ┌ﾐ Βぎ ヴヴΒが ヲヰヱΑく Αヰヰ 
ヵヰく RWｷS Jが MIKWﾐﾐ; HPが Fｷデ┣ゲｷﾏﾗﾐゲ Dが ;ﾐS MIC;ﾐIW TVく Aﾐ W┝ヮﾉﾗヴ;デｷﾗﾐ ﾗa デｴW W┝ヮWヴｷWﾐIW ﾗa I;ﾐIWヴ I;IｴW┝ｷ;ぎ ┘ｴ;デ Αヰヱ 
ヮ;デｷWﾐデゲ ;ﾐS デｴWｷヴ a;ﾏｷﾉｷWゲ ┘;ﾐデ aヴﾗﾏ ｴW;ﾉデｴI;ヴW ヮヴﾗaWゲゲｷﾗﾐ;ﾉゲく E┌ヴﾗヮW;ﾐ ﾃﾗ┌ヴﾐ;ﾉ ﾗa I;ﾐIWヴ I;ヴW ヱΓぎ ヶΒヲどヶΒΓが ヲヰヱヰく Αヰヲ 
ヵヱく Rﾗｪﾐゲデ;S Rが ;ﾐS K;デ┣ Jく TｴW WaaWIデ ﾗa ヲがヴどSｷﾐｷデヴﾗヮｴWﾐﾗﾉ ﾗﾐ ;SｷヮﾗゲWどデｷゲゲ┌W ﾏWデ;Hﾗﾉｷゲﾏく BｷﾗIｴWﾏ J ヱヱヱぎ ヴンヱどヴヴヴが Αヰン 
ヱΓヶΓく Αヰヴ 
ヵヲく Rﾗﾏ;ﾐWﾉﾉﾗ Vが ;ﾐS S;ﾐSヴｷ Mく MｷデﾗIｴﾗﾐSヴｷ;ﾉ Q┌;ﾉｷデ┞ Cﾗﾐデヴﾗﾉ ;ﾐS M┌ゲIﾉW M;ゲゲ M;ｷﾐデWﾐ;ﾐIWく Fヴﾗﾐデ Pｴ┞ゲｷﾗﾉ ヶぎ ヴヲヲが Αヰヵ 
ヲヰヱヵく Αヰヶ 
ヵンく SｷSﾗゲゲｷゲ LSが PﾗヴデWヴ Cが S;ヴ;a MKが BﾗヴゲｴWｷﾏ Eが R;Sｴ;ﾆヴｷゲｴﾐ;ﾐ RSが Cｴ;ﾗ Tが Aﾉｷ Aが CｴﾗﾐSヴﾗﾐｷﾆﾗﾉ; Mが MﾉI;ﾆ Rが ΑヰΑ 
FｷﾐﾐWヴデ┞ CCが H;┘ﾆｷﾐゲ HKが Tﾗﾉｷ┗WヴどKｷﾐゲﾆ┞ Tが ;ﾐS HWヴﾐSﾗﾐ DNく Bヴﾗ┘ﾐｷﾐｪ ﾗa S┌HI┌デ;ﾐWﾗ┌ゲ WｴｷデW ASｷヮﾗゲW Tｷゲゲ┌W ｷﾐ ΑヰΒ 
H┌ﾏ;ﾐゲ ;aデWヴ SW┗WヴW ASヴWﾐWヴｪｷI SデヴWゲゲく CWﾉﾉ MWデ;H ヲヲぎ ヲヱΓどヲヲΑが ヲヰヱヵく ΑヰΓ 
ヵヴく SデWｷﾐaWﾉSWヴ HJが ;ﾐS Jﾗﾗゲデ HGく RW┗WヴゲｷHﾉW ヴWS┌Iデｷﾗﾐ ﾗa ｷﾐゲ┌ﾉｷﾐ ヴWIWヮデﾗヴ ;aaｷﾐｷデ┞ H┞ ATP SWヮﾉWデｷﾗﾐ ｷﾐ ヴ;デ ;SｷヮﾗI┞デWゲく Αヱヰ 
BｷﾗIｴWﾏ J ヲヱヴぎ ヲヰンどヲヰΑが ヱΓΒンく Αヱヱ 
ヵヵく T┣ｷﾆ; AAが FﾗﾐデWゲどOﾉｷ┗Wｷヴ; CCが SｴWゲデﾗ┗ AAが Cﾗﾐゲデ;ﾐデｷﾐﾗ┌ Cが Pゲ┞Iｴﾗｪｷﾗゲ Nが Rｷｪｴｷ Vが Mｷﾐデ┣ﾗヮﾗ┌ﾉﾗゲ Dが B┌ゲケ┌Wデゲ Sが Αヱヲ 
LﾗヮW┣どSﾗヴｷ;ﾐﾗ FJが Mｷﾉﾗデ Sが LWヮｷﾐW Fが MｷﾐSヴｷﾐﾗゲ MNが R;ｴﾏW LGが ;ﾐS AヴｪｷﾉWゲ JMく SﾆWﾉWデ;ﾉ ﾏ┌ゲIﾉW ﾏｷデﾗIｴﾗﾐSヴｷ;ﾉ Αヱン 
┌ﾐIﾗ┌ヮﾉｷﾐｪ ｷﾐ ; ﾏ┌ヴｷﾐW I;ﾐIWヴ I;IｴW┝ｷ; ﾏﾗSWﾉく Iﾐデ J OﾐIﾗﾉ ヴンぎ ΒΒヶどΒΓヴが ヲヰヱンく Αヱヴ 
ヵヶく Vｷゲ;┗;Sｷ┞; NPが KW;ゲW┞ MPが R;┣ゲﾆ;┣ﾗ┗ゲﾆｷ┞ Vが B;ﾐWヴﾃWW Kが Jｷ; Cが Lﾗ┗ｷﾐゲ Cが Wヴｷｪｴデ GLが ;ﾐS H;ｪｪ Tく IﾐデWｪヴｷﾐどFAK Αヱヵ 
ゲｷｪﾐ;ﾉｷﾐｪ ヴ;ヮｷSﾉ┞ ;ﾐS ヮﾗデWﾐデﾉ┞ ヮヴﾗﾏﾗデWゲ ﾏｷデﾗIｴﾗﾐSヴｷ;ﾉ a┌ﾐIデｷﾗﾐ デｴヴﾗ┌ｪｴ STATンく CWﾉﾉ Cﾗﾏﾏ┌ﾐ Sｷｪﾐ;ﾉ ヱヴぎ ンヲが ヲヰヱヶく Αヱヶ 
ヵΑく Vｷゲ;┗;Sｷ┞; NPが MIE┘Wﾐ MLが P;ﾐS┞; JDが S┌ﾉﾉｷ┗;ﾐ PGが G┘;ｪ BJが ;ﾐS SヮヴｷﾐｪWヴ JEく Aﾐデｷﾗ┝ｷS;ﾐデ ヮヴﾗヮWヴデｷWゲ ﾗa ΑヱΑ 
NW┌ヲヰヰヰ ﾗﾐ ﾏｷデﾗIｴﾗﾐSヴｷ;ﾉ aヴWW ヴ;SｷI;ﾉゲ ;ﾐS ﾗ┝ｷS;デｷ┗W S;ﾏ;ｪWく Tﾗ┝ｷIﾗﾉ Iﾐ Vｷデヴﾗ ヲΑぎ ΑΒΒどΑΓΑが ヲヰヱンく ΑヱΒ 
ヵΒく ┗ﾗﾐ H;Wｴﾉｷﾐｪ Sが ;ﾐS AﾐﾆWヴ SDく C;IｴW┝ｷ; ;ゲ ; ﾏ;ﾃﾗヴ ┌ﾐSWヴWゲデｷﾏ;デWS ;ﾐS ┌ﾐﾏWデ ﾏWSｷI;ﾉ ﾐWWSぎ a;Iデゲ ;ﾐS ΑヱΓ 
ﾐ┌ﾏHWヴゲく J C;IｴW┝ｷ; S;ヴIﾗヮWﾐｷ; M┌ゲIﾉW ヱぎ ヱどヵが ヲヰヱヰく Αヲヰ 
ヵΓく WｴｷデW JPが B;┞ﾐWゲ JWが WWﾉﾉW SLが KﾗゲデWﾆ MCが M;デWゲｷI LEが S;デﾗ Sが ;ﾐS C;ヴゲﾗﾐ JAく TｴW ヴWｪ┌ﾉ;デｷﾗﾐ ﾗa ゲﾆWﾉWデ;ﾉ ﾏ┌ゲIﾉW Αヲヱ 
ヮヴﾗデWｷﾐ デ┌ヴﾐﾗ┗Wヴ S┌ヴｷﾐｪ デｴW ヮヴﾗｪヴWゲゲｷﾗﾐ ﾗa I;ﾐIWヴ I;IｴW┝ｷ; ｷﾐ デｴW AヮIふMｷﾐっЩぶ ﾏﾗ┌ゲWく PﾉﾗS ﾗﾐW ヶぎ Wヲヴヶヵヰが ヲヰヱヱく Αヲヲ 
ヶヰく X┌ Hが Cヴ;┘aﾗヴS Dが H┌デIｴｷﾐゲﾗﾐ KRが Yﾗ┌デ┣ DJが L┌IIｴWゲｷ PAが VWﾉデWﾐ Mが MIC;ヴデｴ┞ DOが ;ﾐS WﾗﾉS LEく M┞ﾗI;ヴSｷ;ﾉ Αヲン 
S┞ゲa┌ﾐIデｷﾗﾐ ｷﾐ ;ﾐ ;ﾐｷﾏ;ﾉ ﾏﾗSWﾉ ﾗa I;ﾐIWヴ I;IｴW┝ｷ;く LｷaW ゲIｷWﾐIWゲ ΒΒぎ ヴヰヶどヴヱヰが ヲヰヱヱく Αヲヴ 
ヶヱく Zｴﾗ┌ Xが W;ﾐｪ JLが L┌ Jが Sﾗﾐｪ Yが K┘;ﾆ KSが Jｷ;ﾗ Qが RﾗゲWﾐaWﾉS Rが CｴWﾐ Qが BﾗﾗﾐW Tが SｷﾏﾗﾐWデ WSが L;IW┞ DLが GﾗﾉSHWヴｪ Αヲヵ 
ALが ;ﾐS H;ﾐ HQく RW┗Wヴゲ;ﾉ ﾗa I;ﾐIWヴ I;IｴW┝ｷ; ;ﾐS ﾏ┌ゲIﾉW ┘;ゲデｷﾐｪ H┞ AIデRIIB ;ﾐデ;ｪﾗﾐｷゲﾏ ﾉW;Sゲ デﾗ ヮヴﾗﾉﾗﾐｪWS ゲ┌ヴ┗ｷ┗;ﾉく CWﾉﾉ Αヲヶ 









Figure Legends Αンヴ 
Figure 1.  Weight loss and organ atrophy in colon-26 tumor-induced cachexia  Αンヵ 
(a) Body weight changes of PBS Weight-Stable (n=4), C26 Weight-Stable (n=6), C26 Moderate (n=7), and C26 Αンヶ 
Severe (n=6).  (b) Tumor weights of experimental groups.  (c) Skeletal muscle wet weights of plantaris (PLT), ΑンΑ 
gastrocnemius (GAS), and quadriceps (QUAD).  (d) Epididymal white adipose tissue (WAT) wet weight.  WAT ΑンΒ 
was not detected (ND) in C26 severe group.  (e-f) Wet weight of spleen (e) and liver (f).  (g) Representative ΑンΓ 
myofiber cross-sections of gastrocnemius muscle imaged at 20x.  Imaged cross-sections were analyzed for all Αヴヰ 
mice excluding n=1 from C26 Weight-Stable, and n=2 from C26 Severe due to unavailable tissue mounts (total Αヴヱ 
analyzed n=20).  (h) Mean myofiber cross-sectional area.  (i) Fiber size distribution between groups displayed Αヴヲ 
as relative frequency (percentage).  Data presented as mean ± SE.  Differences determined by one-way Αヴン 
ANOVA.  p<0.05 (*), p<0.01 (**), p<0.001 (***).  Αヴヴ 
 Αヴヵ 
Figure 2.  Impairment of complex I-linked skeletal muscle mitochondrial respiration in severe cachexia.  Αヴヶ 
(a) Mass-specific oxygen (O2) flux of gastrocnemius muscle determined in situ by a substrate-uncoupler-ΑヴΑ 
inhibitor titration protocol, including fatty acid supported LEAK (FAOL) through addition of malate and palmitoyl-ΑヴΒ 
carnitine (M+PC); fatty acid supported oxidative phosphorylation (OXPHOS) (FAOP) by addition of adenosine ΑヴΓ 
diphosphate (ADP); complex I supported OXPHOS (CIP) by addition of pyruvate and glutamate (P+G); Αヵヰ 
complex I+II supported OXPHOS (CI+IIP) by addition of succinate (S); maximal electron transfer system (ETS) Αヵヱ 
capacity (CI+IIE) by stepwise addition of carbonyl cyanide m-chlorophenyl hydrazine (CCCP); and complex II Αヵヲ 
ETS (CIIE) by addition of rotenone (Rot).  (b) Flux control ratio for complex I supported OXPHOS (CIP/CI+IIE).  Αヵン 
(c) Substrate control ratio (SCR) for succinate calculated by dividing CI+IIP by CIP.  (d) Citrate synthase Αヵヴ 
enzyme activity in gastrocnemius muscle homogenate.  (e) Hydrogen peroxide (H2O2) production in quadriceps Αヵヵ 
muscle mitochondria.  Data presented as mean ± SE.  Tissues assayed from PBS Weight-Stable (n=4), C26 Αヵヶ 
Weight-Stable (n=6), C26 Moderate (n=7), and C26 Severe (n=6).  Differences determined by one-way ΑヵΑ 






Figure 3.  AMPK activation and ADP transport proteins in skeletal muscle of colon-26 mice.  Αヶヲ 
(a-b) Immunoblots for p-AMPKg, AMPKg, mitochondrial creatine kinase (CKMT2), Ant2, and tubulin in skeletal Αヶン 
muscle homogenate.  (c) p-AMPKg expression normalized to total AMPKg.  (d) CKMT2 normalized to tubulin.  Αヶヴ 
(e)  Ant2 normalized to tubulin.  Data presented as mean ± SE.  Tissues assayed from PBS Weight-Stable Αヶヵ 
(n=4), C26 Weight-Stable (n=6), and C26 Moderate (n=7).  Differences determined by one-way ANOVA.  Αヶヶ 
p<0.05 (*), p<0.01 (**).  ΑヶΑ 
 ΑヶΒ 
Figure 4.  Increased respiratory rates and uncoupling in white adipose tissue (WAT).  ΑヶΓ 
(a) Mass-specific oxygen (O2) flux of WAT determined in situ by a substrate-uncoupler-inhibitor titration ΑΑヰ 
protocol, including complex I supported LEAK (CIL) through addition of malate (M), pyruvate (P), palmitoyl-ΑΑヱ 
carnitine (PC), and glutamate (G); complex I supported oxidative phosphorylation (OXPHOS) (CIP) by addition ΑΑヲ 
of adenosine diphosphate (ADP); complex I+II supported OXPHOS (CI+IIP) by addition of succinate (S); ΑΑン 
maximal electron transfer system (ETS) capacity (CI+IIE) by stepwise addition of carbonyl cyanide m-ΑΑヴ 
chlorophenyl hydrazine (CCCP); and complex II ETS (CIIE) by addition of rotenone (Rot).  (b) Respiratory ΑΑヵ 
control ratio (RCR) determined by dividing CIP by CIL.  (c) L/P determined by dividing CIL by CIP.  (d) Ratio of ΑΑヶ 
CIL and maximal OXPHOS (CI+IIP).  (e) Ratio of CIL and maximal ETS capacity (CI+IIE).  (f) Cardiolipin content ΑΑΑ 
in WAT homogenate.  Data presented as mean ± SE.  Tissues assayed from PBS Weight-Stable (n=4), C26 ΑΑΒ 
Weight-Stable (n=6), and C26 Moderate (n=7).  Epididymal WAT was not detected in C26 Severe and thus ΑΑΓ 
unavailable for analysis.  Differences determined by one-way ANOVA.  p<0.05 (*), p<0.01 (**), p<0.001 (***).  ΑΒヰ 
 ΑΒヱ 
Figure 5.  Early loss of liver respiratory function and coupling efficiency in colon-26 mice. ΑΒヲ 
(a) Mass-specific oxygen (O2) flux of liver measured in situ by a substrate-uncoupler-inhibitor titration protocol,  ΑΒン 
including complex I supported LEAK (CIL) through addition of malate (M), pyruvate (P), palmitoyl-carnitine ΑΒヴ 
(PC), and glutamate (G); complex I supported oxidative phosphorylation (OXPHOS) (CIP) by addition of ΑΒヵ 
adenosine diphosphate (ADP); complex I+II supported OXPHOS (CI+IIP) by addition of succinate (S); maximal ΑΒヶ 
electron transfer system (ETS) capacity (CI+IIE) by stepwise addition of carbonyl cyanide m-chlorophenyl ΑΒΑ 
hydrazine (CCCP); and complex II ETS (CIIE) by addition of rotenone (Rot).  (b) Respiratory control ratio ΑΒΒ 
(RCR), calculated by dividing CIP by CIL.  (c) Ratio between CIL and maximal OXPHOS (CI+IIP).  (d) The P/E ΑΒΓ 
ヲΑ 
 
ratio, calculated as maximal OXPHOS (CI+IIP) divided by maximal ETS capacity (CI+IIE).  (e) Citrate synthase ΑΓヰ 
enzyme activity in liver homogenate.  (f) Hydrogen peroxide (H2O2) production in liver mitochondria.  (g) ΑΓヱ 
Cardiolipin content in liver mitochondria.  Data presented as mean ± SE.  Tissues assayed from PBS Weight-ΑΓヲ 
Stable (n=4), C26 Weight-Stable (n=6), C26 Moderate (n=7), and C26 Severe (n=6).  Differences determined ΑΓン 
by one-way ANOVA.  p<0.05 (*), p<0.01 (**), p<0.001 (***).  ΑΓヴ 
 ΑΓヵ 
Figure 6.  Elevated expression of Ant2 but not Ucp2 in cachectic liver mitochondria of colon-26 mice. ΑΓヶ 
 (a) Immunoblots for Ucp2, Ant2, and VDAC in mitochondrial lysates from the liver.  (b) Immunoblots for p-ΑΓΑ 
AMPK, AMPK, and tubulin in liver homogenate.  (c)  Ucp2 expression normalized to VDAC.  (d)  Ant2 ΑΓΒ 
expression normalized to VDAC.  (e)  p-AMPK normalized to total AMPK.  (f)  Association of Ant2 expression ΑΓΓ 
with respiratory control ratio (RCR) in the liver.  Data presented as mean ± SE.  Tissues assayed from PBS Βヰヰ 
Weight-Stable (n=4), C26 Weight-Stable (n=6), C26 Moderate (n=7), and C26 Severe (n=6).  Differences Βヰヱ 
determined by one-way ANOVA.  p<0.05 (*), p<0.01 (**).  Βヰヲ 
 Βヰン 
Figure 7.  Proposed mechanisms linking tissue-specific mitochondrial function to cancer cachexia. Βヰヴ 
During the induction of moderate cachexia, mitochondrial respiration is impacted in white adipose tissue and Βヰヵ 
liver, but not skeletal muscle.  White adipose mitochondria show drastically elevated LEAK respiration, a Βヰヶ 
surrogate of proton leak.  The drastic expansion of LEAK lowers the respiratory control ratio (RCR), an index of ΒヰΑ 
oxidative phosphorylation (OXPHOS) coupling efficiency.  Thus, white adipose mitochondria are uncoupled, ΒヰΒ 
and this may increase resting energy expenditure (REE) and cause involuntary weight loss.  In severe ΒヰΓ 
cachexia, white adipose becomes depleted and measurements of respiration are not available (N/A).  In the Βヱヰ 
cachexic liver, mitochondria are also uncoupled, due to reduced OXPHOS and increased LEAK.  Cardiolipin Βヱヱ 
content is increased, which contributes to LEAK and uncoupling.  The persistent elevation of cardiolipin across Βヱヲ 
cachexia severity suggests a role for this inner membrane phospholipid in the maintenance of the cachexic Βヱン 
state.  Adenine nucleotide translocase 2 (Ant2) also contributes to uncoupling in the liver, and is only increased Βヱヴ 
in severe cachexia, suggesting that the transition to severe disease may depend on hepatic Ant2.  Cachexic Βヱヵ 
liver mitochondria, therefore, are uncoupled and energetically inefficient, which may increase energy Βヱヶ 
expenditure and cause unintended weight loss.  In skeletal muscle, impairment of OXPHOS occurs primarily in ΒヱΑ 
ヲΒ 
 
severe cachexia due to dysfunction at complex I (CI).  Attempted compensation occurs by electron supply into ΒヱΒ 
complex II, as reflected by the increased substrate control ratio (SCR) for succinate.  Restricted ATP provision ΒヱΓ 
from impaired OXPHOS in skeletal muscle may contribute to atrophy, exercise intolerance and fatigue in Βヲヰ 
cachexic cancer patients, thereby reducing quality of life.  AMPK, adenosine monophosphate-activated protein Βヲヱ 
kinase.  CKMT2, mitochondrial creatine kinase 2.  Βヲヲ 
 Βヲン 
Figure S1.   Βヲヴ 
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 Βヲヶ 
Figure S2.   ΒヲΑ 
doi.org/10.6084/m9.figshare.7881110.v1 ΒヲΒ 
 ΒヲΓ 
Figure S3.   Βンヰ 
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